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Abstract 
This study investigates four halogenated substances; three polyfluorinated compounds and 
one brominated substance. The polyfluorinated compounds, namely 6:2 fluorotelomer alcohol 
(6:2 FTOH), 8:2 fluorotelomer alcohol (8:2 FTOH) and perfluorooctanoic acid (PFOA), are 
widespread anthropogenic compounds, used in a variety of consumer products due to their 
water-, grease- and stain-repellent property. Levels of PFOA in human blood are typically 
around 5 ppb (0.01 µM), while FTOHs so far not have been measured in human samples due 
to technical difficulties. One of the main effect of PFOA in laboratory animals and in in vitro 
experiments is an induction of peroxisomal proliferation, leading to increased oxidation of fat, 
changed expression of a variety of genes, and increased cell proliferation, possibly inducing 
cancer development, both in the liver and in the pancreas and testicle. PFOA is also a 
reproductive toxicant, changes membrane architecture, and inhibits the effluent transporter P-
gp. Several of the effects of the FTOHs are similar to those observed after PFOA exposure 
and several of the genes that show altered expression after PFOA exposure are also changed 
after exposure to 8:2 FTOH. Effects of 8:2 FTOH exposure include hepatocellular necrosis 
and peroxisomal proliferation, as well as detrimental effects on development in mice. Both 
6:2 and 8:2 FTOH have been shown to act as xenoestrogens in vitro.  
 We evaluated the effect of 6:2, 8:2 FTOH and PFOA on testicular cells from Wistar 
rats. Testicular cells were exposed in vitro to concentrations up to 300 µM for one hour. No 
signs of cytotoxicity were observed. The level of single strand breaks, abasic sites and 
oxidized purines was not increased, either. Whether the expression of the breast cancer 
resistant protein (Bcrp1) was altered, remains unsure due to high variability between 
experimental runs. One major weakness in these experiments is the use of a relatively short 
exposure time, making it very difficult to draw conclusions. Since the tested concentrations 
are many magnitudes higher than exposure in the general population, the data have 
nonetheless predictive value. Taken together, the results suggest that the tested PFCs do not 
exhibit testicular toxicity.  
 The brominated compound 1,2-dibromo-3-chloropropane (DBCP) is known to induce 
permanent or temporary infertility in men, in addition to being a renal toxicant. It also induced 
DNA damage and acts as a clastogen and mutagen, inducing cancer development. The DNA 
inducing effect of DBCP on three testicular cell types was evaluated; Sertoli cells and other 
somatic cells seem to be the most sensitive cell type, spermatogonia the least sensitive, and 
spermatids seem to have a medium sensitivity. However whether the results obtained in 
experiments with somatic cells are correct is quite uncertain due to prolonged perincubation 
 4 
time. The repair capacity in spermatogonia and spermatids was also examined; spermatogonia 
were found to repair DNA damage induced by DBCP somehow faster than spermatids. Taken 
together, the results suggest that it may be the supporting cells like Sertoli cells that get 
heaviest damaged by DBCP. The damage in these cells can then lead to impaired germ cell 
development by interfering with the supply of nutrition, testosterone and other supporting 
functions. Spermatogonia appear to be least sensitive and repair the induced DNA damage 
relatively effectively. Since these cells are located outside of the blood-testis barrier these 
efficient defense mechanisms are very meaningful. 
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Aim of study 
The number of man-made substances is ever increasing. Many of these substances become 
widespread in the environment, but the effects these have on human health are not always 
known. Risk assessment is a method for evaluating the detrimental effects of chemical 
substances. To be able to perform a risk assessment, the intrinsic effects of a component have 
to be known, as well as “safe” levels and exposure scenarios. This study attempts to 
contribute to all these parts of the risk assessment by performing a literature study to evaluate 
the existing information on toxicity of the components, as well as identify areas where further 
research is needed. A component of this part is also the assessment of human exposure. 
However, this has proven to be difficult due to lack of data concerning several of the 
examined components. Further on, this study tries to fill some of the knowledge gaps by 
performing experiments. Four substances where chosen in this study: 6:2 fluorotelomer 
alcohol (6:2 FTOH), 8:2 fluorotelomer alcohol (8:2 FTOH), perfluorooctanoic acid (PFOA), 
and 1,2-dibromo-3-chloroporoane (DBCP). No information concerning the testicular toxicity 
of the polyfluorinated compounds (PFCs) could be found, so this was identified as one of the 
main areas where further research was needed. DBCP on the other hand, was used as a 
positive control in the experiments with the PFCs, since it is known to be a testicular toxicant. 
Due to a difference in response found in different testicular cell types after DBCP exposure, 
this compound was studied in more detail.  
 
The overall aim of the study is thus to contribute to a risk assessment of the four 
halogenated compounds by summing up existing information, but also creating new 
information. To achieve this, five goals were identified: 
1. Perform a literature study on the selected halogenated compounds. 
2. Evaluate the toxicity of three selected fluorinated compounds on adult testicular cells 
regarding their 
a. Cytotoxicity  
b. DNA damaging effect 
c. Gene expression alterations 
3. Evaluate a simplified method for isolation and purification of spermatogonia from 
prepubertal rats. 
4. Investigate the difference in susceptibility of various testicular cell populations 
towards DNA damaging effects of DBCP. 
5. Assess a possible difference in repair efficiency in spermatids and spermatogonia after 
exposure to DBCP. 
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1. Introduction and background 
An undisturbed reproductive process is not only important for the survival of the species, but 
it is also fairly important for each person individually. In Western countries, one out of seven 
couples is experiencing fertility problems, of which at least half have unknown causes (Olive 
and Cuzin, 2005). Many factors can intervene with the reproductive process and lead to 
reduced fertility; examples are genetic disorders, lifestyle factors, disease, and exposure to 
chemicals or radiation. One of the first references to a chemical interfering with reproduction 
is made by Aulus Gellius (ca 125-180 A.D.), cited in Robert Burtons Anatomy of 
Melancholy: “If a drunken man get a child it will never likely have a good brain” (Burton, 
2001). Negative effects in both males and females are known, and yet research on effects of 
chemical agents has focused on female reproduction until the 1990s. One of the reasons for 
increased focus on effects in males is the observed increase in testicular dysfunction, 
anomalies and cancer, as well as decreased semen quality during the recent 60 years. This is 
believed to be due to environmental factors as well as lifestyle factors. The reduced male 
fertility can be due to a number of disturbances in the testicle; examples being the cell death 
of either the supporting cells or the germ cells, disturbance of hormonal balance leading to 
reduced sperm production, or DNA damage in germ cells, leading to apoptosis of the cell, 
inferior sperm quality possibly leading to reduced fertility and in severe cases to 
malformations and genetic defects in offspring. 
 
In this study, two classes of compounds are surveyed: a well known reproductive toxicant, 
dibromochloropropane (DBCP), and a class of fairly “new” chemicals, polyfluorinated 
compounds (PFCs). DBCP is chosen to study the mechanism of testicular toxicity and as a 
positive control for experiments with the PFCs. We are especially interested in determining 
which period of germ cell development is most sensitive to lesions induced by DBCP. The 
polyfluorinated compounds are chosen because they are found in blood samples at quite high 
concentrations and are shown to induce reproductive defects in offspring following in vivo 
exposure, but have not been studied regarding their testicular toxicity. All compounds are 
evaluated regarding their cytotoxicity to testicular cells, as well as their DNA damaging 
effect. The polyfluorinated substances are also evaluated concerning their effect on gene 
expression of an efflux transporter pump, namely the breast cancer resistance protein 
(Bcrp1/Abcg2).  
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The introduction will therefore first give a summary of the available literature on the four 
selected halogenated compounds. Sources, toxicity and epidemiology of the surveyed 
compounds will be described. This is followed by an overview of the structure of the male 
reproductive system and different testicular cells and their functions, as well as DNA damage. 
Also, the function of the breast cancer resistance protein and other effluent transporters will 
be described.  
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1.1 Polyfluorinated compounds (PFC) – a literature overview 
Polyfluorinated compounds (PFCs) are entirely man-made compounds and have been used 
since the 1950s (Poulsen et al., 2005). They consist of a carbon chain where some or all of the 
hydrogen atoms have been replaced by fluorine atoms. The carbon-fluor bond is the strongest 
of all covalent bounds and resists hydrolysis, photolysis, biodegradation, and metabolism 
(Guruge et al., 2006). This makes PFCs highly stable and persistent in the environment. PFCs 
have different functional groups like sulphate, acid or alcohol, which make one end of the 
molecule hydrophilic. The other end, containing fluorosubstitued carbon atoms, is 
hydrophobic, resulting in the molecule being amphipathic. This property makes PFCs water-, 
grease- and oil-repellent and therefore useful in a range of consumer products. PFCs are used 
in textile surface treatments, paper coatings, lubricants, fire retardants, electronics, waxes, 
polish, aerospace, paint-additives, and non-stick coatings for cookware, and many other 
applications. They are released during the production of consumer products, as well as during 
use of products.  
PFCs ultimately end up in the environment and are found in a diversity of 
environmental samples: air, water, wild animals and birds, and foodstuff (Smith, 2001; 
Kannan et al., 2002; Martin et al., 2004; Skutlarek et al., 2006; Barber et al., 2007; Ericson et 
al., 2007). The three PFCs found at the highest concentrations in air samples in Northwest 
Europe are PFOA, 6:2 fluorotelomer alcohol (FTOH) and 8:2 FTOH (Barber et al., 2007). 
Additionally, PFCs are measured in samples from humans, including blood (Taves, 1968; 
Olsen, 2007) and breast milk (So et al., 2006).  
Because of the highly stable bond between carbon and fluorine, PFCs were historically 
considered metabolically inert and non-toxic (Sargent and Seffl, 1970). However, during the 
1990s, evidence has accumulated of biological activity of PFCs and their toxic effects such as 
peroxisome proliferation, increased lipid metabolizing enzyme activity, and induction of 
Leydig cell adenomas and pancreatic and hepatic tumors (Sohlenius et al., 1994; Obourn et 
al., 1997). 
Many different PFCs have been produced, but due to the scope of this thesis, only 
three PFCs were selected for further analysis: 6:2-fluorotelomer alcohol (6:2 FTOH), 8:2-
fluorotelomer alcohol (8:2 FTOH), and perfluorinated octanoic acid (PFOA). 
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1.1.1 Fluorotelomer alcohol (FTOH) 
The fluorotelomer alcohols (FTOHs) nomenclature are based upon the number of 
perfluorinated carbons in relation to the number of hydrogenated carbons. 8:2 FTOH refers to 
the 1H,1H,2H,2H-perfluoro-1-decanol with 8 carbon atoms being fully fluorinated and two 
carbon atoms without fluor, while 6:2 FTOH is the abbreviation for 1H,1H,2H,2H-Perfluoro-
1-octanol (figure 1).  
 
   
Figure 1: Structure formulas for 6:2 FTOH (left image) and 8:2 FTOH (right image) 
 
There is hardly any information available on the toxicity of 6:2 FTOH so far, so this chapter 
will concentrate on 8:2 FTOH. However, the metabolism and toxicity of different FTOHs 
seem to be quite similar (Martin et al., 2005), so most of the information presented here might 
be valid for 6:2 FTOH as well. 8:2 FTOH has been detected in bottlenose dolphins and arctic 
ringed seals (Houde et al., 2006; Butt et al., 2007). 
 
Use and sources 
FTOHs are used as intermediates in the manufacture of polymers for oil, soil and water 
repellent surface treatment applications, but also in the manufacture of paints, coatings, 
polymers, adhesives, waxes, polishes, electronics, and caulk. They get linked to the product 
via an ether-, urethane-, or ester-bond. When these bonds are not fully established during 
production, or when the bonds are degraded, FTOHs get released. The global annual 
production of FTOHs was estimated to 11-14 million kg in 2003 (Ellis et al., 2003). DuPont 
reports a doubling of FTOH sales from 2000 to 2005 (Dupont, 2005). The FTOH used in the 
largest amount is 8:2 FTOH (Nabb et al., 2007). Emitted FTOH can biodegrade to 
perfluorinated acids, 8:2 FTOH is suggested to degrade to a.o. PFOA, while 6:2 FTOH is 
expected to degrade to perfluorohexanoic acid (PFHxA) (Dinglasan et al., 2004).  
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Toxicokinetics 
In rats about 34-50% of 8:2 FTOH is absorbed after oral administration, but the absorption 
following dermal exposure is negligible (<1%). 8:2 FTOH has a very short half-life of less 
than 5 hours in rats (Fasano et al., 2006). In the rat, 70% of 8:2 FTOH is excreted in the 
faeces, and metabolites are found in fat, liver, adrenals, and thyroid (Fasano et al., 2006). The 
main fate of 8:2 FTOH is direct conjugation to form O-glucuronide and O-sulphate, which 
account for about 70% of metabolites (Martin et al., 2005). Hagen et al. (1981) were the first 
to suggest metabolism of 8:2 FTOH to PFOA and 8:2-fluorotelomer acid (FTCA). Martin et 
al. (2005) found the initial step to be oxidation by P450-enzymes to 8-2 fluorotelomer 
aldehyde (FTAL). 8:2 FTAL is oxidized to 8:2-FTUAL or 8:2 FTA, which is further 
metabolized to 8:2 unsaturated acid (FTUA). 8:2 FTUAL can via several steps then form 
PFOA (figure 2). Many different sulphate-, glucoronide- and glutathione-conjugates may be 
formed (Nabb et al., 2007). Nilsen et al. (2008) found that intraperitonally administered 8:2 
FTOH was completely metabolized in Wistar rats within 24 hours . Similar results have been 
reported in exposed mice (Henderson and Smith, 2007). Nabb et al. (2007) examined the 
metabolism of 8:2 FTOH in rat, mouse, trout and human hepatocytes, microsomes and 
cytosols and found the elimination to be about three times faster in rodents than in humans 
and nine times faster than in trout. The amount of PFOA that was formed after 8:2 FTOH 
exposure was low: 0.47, 0.24, 0.02, and 0.02% of 8:2 FTOH was found as PFOA in mouse, 
rat, human and trout hepatocytes, respectively. These findings are in compliance with results 
of others, for instance Martin et al. (2005). Some of the intermediate metabolites have been 
reported to be more toxic than the perfluorocarbocylic acids (Phillips et al., 2007); especially 
the FTUAL and FTUCA may react with cellular nucleophiles like nucleic acid (Martin et al., 
2005). FTOHs with different chain length have been shown to be metabolized to similar 
metabolites, with the only difference being the chain length of the metabolites (Martin et al., 
2005). 
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Figure 2: Metabolic pathway of 8:2 FTOH as suggested by Nabb et al. (2007). This figure incorporates 
pathways suggested by Martin et al. (2005) and Fasano et al. (2006). Metabolites shown in brackets are 
proposed intermediated (Martin et al., 2005; Fasano et al., 2006; Nabb et al., 2007). FTOH: fluorotelomer 
alcohol; FTAL: fluorotelomer aldehyde; FTUAL: α-β unsaturated aldehyd; FTA: fluorotelomer acid; 
FTUA: α-β unsaturated acid; AL: aldehyde; UAL: unsaturated aldehyde; PFOA: perfluorinated octanoic 
acid. 
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Toxicity 
The acute toxicity of 8:2 FTOH is low, with LD50>2000 mg/kg bw in rats (Finlay, 2001). No 
LD50-value for 6:2 FTOH could be found. In rat hepatocytes, concentrations of either 8:2 
FTOH or 6:2 FTOH up to 200 µM did not influence cell viability as measured by the Trypan 
Blue exclusion test (Martin et al., 2005). Exposure to 6:2 or 8:2 FTOH at concentrations up to 
1.1x10-5M (11 µM) for 44 hours did not reduce cell viability in primary cultured Tilapia 
hepatocytes either (Liu et al., 2007a). Stankowski (2001) tested the mutagenicity of 8:2 
FTOH in the Salmonelle typhimurium strains TA98, TA100, TA1535, and TA1537, and 
Escherichia coli strain WP2uvrA. The compound was not found to be mutagenic in any of the 
strains with or without S9 (Stankowski, 2001).  
 In vivo exposure of rodents to 8:2 FTOH lead to similar signs of toxicity as with 
PFOA exposure: increased peroxisomal proliferation and hepatocellular necrosis (see chapter 
1.1.2, toxicity of PFOA) (Ladics, 2003). Nilsen and co-workers found significant alteration of 
the expression of 105 genes following in vivo exposure to 8:2 FTOH (Nilsen et al., 2008). 
Some of the altered genes overlap with genes altered by PFOA exposure; but alteration of 
genes not influenced by PFOA was also found. Other signs of toxicity observed in this study 
include hepatomegaly and induction of peroxisomal β-oxidation. Since no 8:2 FTOH could be 
detected in the liver 24 hours after the exposure, it is unclear whether the toxicity was caused 
by PFOA, 8:2 FTOH, or another metabolite (Nilsen et al., 2008).  
A mixture of different fluorotelomer alcohols (6:2 FTOH, 8:2 FTOH, 10:2-FTOH and 
12:2-FTOH) was evaluated in an in vivo rat developmental and reproductive study by 
Mylchreest et al. (2005a). The authors estimated the NOAEL for reproductive effects to be 25 
mg/kg/day and the NOAEL for developmental effects to be 200 mg/kg/day, with the most 
distinct effects being reduced litter size, and reduced weight gain, as well as fetal skeletal 
alterations (Mylchreest et al., 2005a). The toxicity of different fluorotelomer alcohols is 
assumed to be similar, so the effect of this mixture is likely similar to the effect of one of the 
compounds at a time. This is confirmed by another study by Mylchreest et al. (2005b) where 
rats were exposed to 8:2 FTOH. The NOAEL for maternal and developmental toxicity was 
found to be 200 mg/kg/day (Mylchreest et al., 2005b). Because signs of developmental 
toxicity did not occur prior to signs of maternal toxicity, 8:2 FTOH was not considered a 
selective developmental toxicant in rats. Henderson and Smith (2007) found that in utero 
exposure of mice to 8:2 FTOH lead to an increase of fetal PFOA concentrations. The 
observed accumulation in the foetus was explained by the pH gradient between the maternal 
and the fetal compartment. They also observed an increase in liver weight, mortality and 
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neural tube defects in neonates after administration of 30 mg/kg bw on gestational day 8 and 
classified 8:2 FTOH as a developmental toxicant in mice (Henderson and Smith, 2007).  
Maras et al. (2006) found that both 6:2 FTOH and 8:2 FTOH act as xenoestrogens in 
vitro, with 6:2 FTOH having a slightly stronger potency. The authors report an effect on both 
cell proliferation and estrogenic gene expression. Ishibashi et al. (2007) observed an 
activation of the human estrogen receptor (hER) isoforms hERα and hERβ after incubation 
with 6:2 FTOH and 8:2 FTOH. A stronger induction was seen following 6:2 FTOH exposure 
compared to 8:2 FTOH (Ishibashi et al., 2007). Liu et al. (2007a) came to a similar 
conclusion after detecting induction of vitellogenin in primary cultured Tilapia hepatocytes 
after 48 hours of treatment with 6:2 FTOH, suggesting an estrogenic activity of this 
compound. The authors interpreted this effect to be mediated by the estrogen receptor 
pathway. 8:2 FTOH did not induce vitellogenin. However, all these results are obtained in in 
vitro studies. In the in vivo reproductive study by Mylchreest et al. (2005a), no test-substance-
related effect on estrous cycle parameters was observed. 
 
Human exposure 
FTOHs are absorbed after ingestion and inhalation, so possible exposure routes include air 
(gaseous FTOH as well as FTOH attached to particles) and contaminated food and drinking 
water. FTOHs have been detected in the North American atmosphere, in Europe and in the 
Arctic atmosphere (Stock et al., 2004; Shoeib et al., 2006; Jahnke et al., 2007). Martin et al. 
(2005) estimated that the human exposure was between 0.2 and 2ng FTOH /kg bw/day. This 
was calculated from an outdoor concentration of FTOH of around 10-100 pg/m3 (Martin et 
al., 2005). This seems to be a relatively low estimate, considering that Barber et al. (2007) 
measured the concentration of 6:2 FTOH and 8:2 FTOH in the air to be 11-243 pg/m3 and 5-
189 pg/m3, respectively (Barber et al., 2007). Additionally, measurements made by the same 
group of indoor air showed much higher levels of FTOHs, in the area of ng/m3. Taking into 
consideration that modern human beings spend most of their time indoor, the exposure 
through inhalation is most likely much higher than estimated by Martin et al. (2005). Food 
stuff may be contaminated via packaging material or during preparation. However, no data on 
amounts of FTOH in food could be obtained. Microwave popcorn is wrapped in grease 
repellent paper containing fluorotelomers, and some of these FTOHs are released during 
popping of the popcorn, which can lead to inhalation of FTOH and transfer of FTOH to food 
(Sinclair et al., 2007). This topic is described in more depth below (chapter 1.1.2). 
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1.1.2 Perfluorinated octanoic acid (PFOA) 
Perfluorinated octanoic acid (PFOA) is one of the two PFCs most commonly found in 
environmental samples and is also one of the most studied PFCs. PFOA is a fully fluorinated 
compound, i.e. all hydrogen atoms have been replaced by fluor atoms (figure 3). 
  
 
Figure 3: Structure formula of perfluorinated octanoic acid (PFOA) 
 
Use and sources 
PFOA is a strong surfactant that is mainly used as a reactive intermediate, while its salts are 
used as processing aids in the production of fluoroelastomers, fluoropolymers, and other 
surfactants. PFOA is released directly into the environment, but is also the ultimate 
degradation product of several precursors such as 8:2 FTOH (Dinglasan et al., 2004). The 
estimated global production of PFOA in 2003 was 1200 metric tons (Lau et al., 2007). The 
major PFC-producing companies on a global basis have committed themselves to reducing 
emission of PFOA and related chemicals by 95% by 2010 in the stewardship program 
collaboration with the US Environmental Protection Agency (EPA) (Lau et al., 2007). Typical 
levels in outdoor air are 1-818 pg/m3 (Barber et al., 2007). 
In 2007, the Norwegian Pollution Authority (Statens Forurensninsgstilsynet, SFT) 
estimated the annual emission of PFOA in Norway, the results are presented in table 1 (SFT, 
2007). Their survey concluded that long range transport of PFOA is the most important source 
of PFOA in Norway. The major direct source from consumer products seems to be 
impregnated carpets. SFT has suggested to ban the use of PFOA in consumer products in 
Norway (SFT, 2008a).  
The EU has proposed the classification of PFOA as 
• toxic (T, R48/23: Toxic: danger of serious damage to health by prolonged exposure 
through inhalation),  
• a reproductive toxicant (Repr Cat 2, R61: May cause harm to the unborn child) 
• carcinogenic (Carc Cat 3, R40: Limited evidence of a carcinogenic effect) 
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• irritant (Xn, R20/22: Harmful by inhalation and if swallowed; R48/22: Harmful: danger of 
serious damage to health by prolonged exposure if swallowed), and 
• irritant to the eye (Xi, R36: Irritating to the eyes) (SFT, 2007; Bjørge, 2008). 
 
Table 1: Estimated annual maximum emission of PFOA from consumer products and long range 
transport of PFOA in Norway (SFT, 2007) 
 
Carpets 12 kg 
Coated and impregnated paper 1.2 kg 
Textiles 0.5 kg 
Paint and lacquers 1 kg 
Long range transport 130 to 380 kg 
 
PFOA is found as a residual from the production process in polytetra-fluoroethylene (PTFE) 
films, which are used in non-stick cookware and breathing membranes as in outwear, and as a 
contaminant in fluorochemical coated food-contact paper as microwave popcorn bags. PFOA 
has been shown to migrate from food contact paper and non-stick cookware into water and oil 
(Begley et al., 2005). Begley et al. (2005) found that 4% of the PFOA in the frying pans could 
migrate into water and oil at 100°C during the first use. The same study measured relatively 
large amount of PFOA in paper coating and popcorn bags. Sinclair et al. (2007) measured 
PFOA off-gassing from non-stick cookware under normal cooking temperatures (179-233 
°C), transfer to water boiled in these pans, and release from microwave popcorn. They found 
that PFOA is released from cooking pans with a large difference between brands (table 2). 
The amount released decreased with repeated use in one brands, while it was similar during 
the first 4 uses in another brand. FTOHs were also released during the first use, but not during 
repeated use. In addition, PFOA as well as 6:2 FTOH and 8:2 FTOH are released during the 
popping of microwave popcorn. The amounts released are vary considerable between the 
different brands (table 3) (Sinclair et al., 2007).  
 
Table 2: PFOA emission during use of non-stick cookware under normal cooking temperature, modified 
from (Sinclair et al., 2007) 
 
Sample 
brand 
Gas-phase 
PFOA 
released 
during 1st use 
(pg/cm2) 
Gas-phase 
PFOA 
released 
during 2nd 
use (pg/cm2) 
Gas-phase 
PFOA 
released 
during 3rd 
use (pg/cm2) 
Gas-phase 
PFOA 
released 
during 4th 
use (pg/cm2) 
PFOA 
retained in 
water during 
boiling (ng in 
250 ml) 
pan 4 19    <2,5 
pan 13 67 27 55 67 <2,5 
pan 32 287 145 69 40 75,0 
pan 39 61    7,7 
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Table 3: PFC emission from microwave popcorn, modified from (Sinclair et al., 2007) 
 
Popcorn brand PFOA 
measured in 
the gas phase 
following 
popping (ng) 
6:2 FTOH 
measured in 
the gas phase 
following 
popping (ng) 
8:2 FTOH 
measured in 
the gas phase 
following 
popping (ng) 
PFOA 
measured in 
popcorn paper 
packaging 
(ng/cm2) 
PoP 40 16 223 258 6,0 
PoP 41 17 < 20 < 20 0,5 
Control <2,5 < 20 < 20 < 0,2 
 
Toxicokinetics 
PFOA is readily absorbed after oral intake and inhalation, and can also penetrate the skin 
(Ophaug and Singer, 1980; Kennedy, 1985). PFOA is mainly distributed to kidney, liver, and 
blood where it is bound to albumin, but can also be found in the lung, heart, skin, and testis 
(Vanden Heuvel et al., 1992; Noker and Gorman, 2003). Data by Han et al. (2003) suggest 
that 95% of PFOA in blood is bound to albumin, and Vanden Heuvel and co-workers (1992) 
suggest that protein sulfhydryl groups are the site of the covalent binding to proteins. PFOA 
has been reported to bind to β-lipoproteins and liver fatty acid-binding protein, as well as 
other proteins in liver, plasma and testis (Vanden Heuvel et al., 1992; Luebker et al., 2002). 
PFOA can cross the placenta (Apelberg et al., 2007b) and enters enterohepatic circulation. 
PFOA is eliminated mainly in the urine, but biliary excretion and reabsorbtion occurs (Kudo 
et al., 2001). A study in female rats showed that after a single administration of PFOA, ~90% 
was excreted in the urine and ~10% in the faeces (Ophaug and Singer, 1980). While urine is 
the main route of excretion in rodents, faecal excretion predominates in monkeys and humans 
(Anderson et al., 2008). In rats, PFOA has been found to be transferred to offspring via 
lactation. The PFOA concentration in the breast milk was approximately 10 times lower than 
in maternal serum (Hinderliter et al., 2005). Two human studies show some disagreement 
with respect to transfer of PFOA to human breast milk, with one study showing ppt levels of 
PFOA (So et al., 2006), and the other finding PFOA levels above the detection limit (0.01 
ng/ml, i.e. 0.01 ppb) in only one sample (Karrman et al., 2007).  
There is no metabolism of PFOA in organisms (Ophaug and Singer, 1980). The half-
life varies significantly in different species, ranging from a few hours in rats and rabbits, to 
around 20 days in cynomolgus monkeys and several years in humans (Vanden Heuvel et al., 
1991; Johnson, 1995; Butenhoff et al., 2004b). The mean half-life in retired exposed workers 
is about 4 years, with a range of 1.5-13.49 years (Burris et al., 2002). In some animal species 
large differences in the halv-life of PFOA are observed between the sexes: in female rats the 
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halv-life is 3.7 hours, while it is 7.4 days in male rats (Kudo et al., 2002; Kemper, 2003). The 
half-lifes of PFOA in humans and female rats is thus different with a factor of 35,000. The 
reason for these large species differences are still unknown. In rats, testosterone 
downregulates the elimination of PFOA (Kudo et al., 2001), while estradiol upregulates the 
elimination (Ylinen et al., 1989).  
 
Toxicity 
The oral LD50 of PFOA in rats is 430 mg/kg bw in females and 680 mg/kg bw in males 
(Griffith and Long, 1980). The difference in LD50 value between the sexes is thought to be 
associated with the shorter half-life of PFOA in female rats.  
One of the most distinct effects of subchronic PFOA exposure of murines is an 
induction of peroxisomal proliferation (PP) through the agonistic effect on PPARα, shown in 
rats, mice, common carp and zebrafish (Sohlenius et al., 1994; Anderson et al., 2008). The 
induction of PP is likely responsible for a variety of the effects observed after PFOA exposure 
since it is believed to increase cell proliferation, possibly inducing cancer development, and 
increase oxidation of fat (Kudo et al., 2006). After binding of PFOA to PPARα a 
heterodimers with the retinoid X receptor is formed. This complex is then capable of 
regulating genes exhibiting a peroxisome proliferator response element (PPRE). Many genes 
responsible for lipid homoeostasis are regulated by PPREs (Mandard et al., 2004). Exposure 
to PFOA for 21 days altered gene expression of over 500 genes in the liver of Sprague-
Dawley rats. The induced genes were mainly involved in transport and metabolism of fatty 
acids and lipids, while the downregulated genes were related to transport, inflammation and 
immune response (Guruge et al., 2006). The authors proposed these effects to be due to 
PFOA having a very similar structure to endogenous fatty acids and thereby causing 
interactions with the degradation of unsaturated fatty acids. This theory is supported by 
findings of Luebker et al. (2002) who found PFOA to be able to displace fatty-acid molecules 
bond to Fabp1, a fatty-acid binding protein (Luebker et al., 2002). The induction of 
peroxisomal β-oxidation without induction of catalase could lead to oxidative stress from 
hydrogen peroxide produced from acyl-CoA (Guruge et al., 2006). An effect on gene 
expression was also seen in CD-1 mice exposed to PFOA in utero. Approximately 1500 genes 
in the fetal liver had altered expression, while about 200 genes were influenced in the fetal 
lung. Most of the altered genes were associated with lipid homoeostasis (Rosen et al., 2007). 
A similar result was found by Nilsen et al. (2008), who exposed Wistar albino rats for 10 days 
and found altered expression of 441 genes. Rosen et al. (2008) examined the effect of PFOA 
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on gene expression in PPARα-null mice. A dose of 3 mg/kg significantly altered the 
expression of 879 genes in wild-type mice, but only 176 genes in the knockout mice. This 
suggests that the main effect of PFOA on gene expression is mediated by PPARα activation, 
but that there also are effects on gene expression independent of PPARα. Genes altered in the 
knockout mice were related to fatty acid metabolism, cell cycle progression, inflammation, 
and xenobiotic metabolism (Rosen et al., 2008). In a similar experiment, Wolf et al. (2008) 
exposed wild-type and knockout mice to PFOA and measured liver toxicity. Hepatomegaly 
was observed in both wild-type and knockout mice, while peroxisome proliferation was 
dependent on PPARα. Hepatocellular proliferation increased in a dose-dependent manner in 
wild-type mice, while it was only seen at high PFOA doses in knockout mice. The authors 
hypothesized a possible alternative nuclear receptor-mediated pathway at high PFOA doses 
leading to a mitogenic response not requiring PPARα receptor (Wolf et al., 2008). Yang et al. 
came to a similar conclusion after observing liver enlargement following PFOA exposure in 
PPARα-null mice (Yang et al., 2002). 
There is though some disagreement concerning the genotoxic effect of PFOA; it has 
tested negative in the Ames test at concentrations up to 500 µM, suggesting no mutagenic 
effect (Freire et al., 2008). It has also tested negative in several genotoxicity studies (Litton 
Bionetics, 1978; Hazleton, 1995; Toxicon, 2002), but Yao et al. (2005) showed that PFOA 
was genotoxic in the human hepatocellular liver carcinoma cell line HepG2 cells, inducing 
single strand breaks and generating ROS. They hypothezied, however, that the genotoxic 
effect might be a secondary effect of the ROS generation (Yao and Zhong, 2005).  
Although it appears that PFOA is not directly genotoxic, it has been shown to cause an 
increase in incidence in liver tumours, pancreatic acinar cell tumors, fibroadenomas of the 
mammary gland, and testicular Leydig cell adenomas in rats at 300 ppm (Riker, 1987; Biegel 
et al., 2001; Anderson et al., 2008). Both hepatic tumor, Leydig cell-tumor and pancreatic 
acinar cell-tumor are often observed following exposure to PPs (Reddy and Rao, 1977; Cook 
et al., 1999). A possible mechanism for the induction of Leydig cell tumor is the alteration of 
gene expression regulated by PPREs, which are responsible for hormone homeostasis. An 
induction of CYP19A1 causes an increase in estradiol, which is thought to induce Leydig cell 
tumor (Cook et al., 1999; Biegel et al., 2001). Another possible explanation for cancer 
induction in Leydig cells is that the disturbed testosterone biosynthesis after exposure to PPs 
leads to reduced testosterone levels, which leads to a compensatory increase in lutenizing 
hormone. This leads then to increases Leydig cell proliferation (Liu et al., 1996; Clegg et al., 
1997; Biegel et al., 2001). 
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Several authors report effects of PFOA on reproduction, including delay in growth, 
development, eye-opening and onset of puberty in offspring (reviewed by Lau et al., 2004). In 
addition, in uterus exposed mice died soon after delivery (Lau et al., 2006). Some of these 
effects seem to be PPARα dependent, while other effects such as prenatal lethality were seen 
in PPARα-null mice as well (Abbott et al., 2007). Decreases in weight and reduced weight 
gain can be due to the PP effect which leads to increased oxidation of fat.  
Whether these toxicity findings in rodents are relevant for human toxicity is yet  
unclear. PPARα-activation is most likely not a relevant mode-of-action in humans because of 
the much lower expression in humans compared to rats and major differences in downstream 
response elements (Cheung et al., 2004). For instance Morimura et al. (2006) showed that an 
induction of the mouse PPARα receptor lead to inhibition of apoptosis, while activation of the 
human PPARα receptor stimulated apoptosis. Therefore, several of the effects observed in 
rodents following PFOA exposure might not accure in humans. 
Due to the large differences between murines and humans with respect to response to 
PPARα inducers, PFOA has been tested in in vivo experiments using monkeys. Decreased 
thyroid levels, increased liver weight and hepatic changes, as well as marked diffuse lipid 
depletion in the adrenals were observed (Griffith and Long, 1980; Butenhoff et al., 2002). 
PFOA has also been shown to induce apoptosis in the monkey kidney-derived cell line Vero 
at concentrations of 50 µM for 24 hours (Freire et al., 2008). An increase in intracellular H2O2 
levels and thereby oxidative stress was also observed. 
PFOA seems to alter membrane architecture (Levitt and Liss, 1987) and increase the 
nonselective permeability of mitochondrial membranes, possibly leading to metabolic wasting 
(Starkov and Wallace, 2002). The effect on membrane fluidity can possibly be caused by the 
downregulating influence PFOA has on cholesterol synthesis (Guruge et al., 2006). Another 
hypothesis is that PFOA acts as a strong detergent and disrupts the inner membrane of the 
mitochondria, thereby decreasing respiratory control, increasing oxidative stress, and possibly 
causing apoptosis (Panaretakis et al., 2001). In the human hepatocellular liver carcinoma cell 
line (HepG2), PFOA induces generation of ROS and mitochondrial hypergeneration at 400 
µM for 3 hours (Panaretakis et al., 2001).  
PFOA has also been shown to be toxic to aquatic organisms. For instance, exposure to 
PFOA for 24 hours reduced viability in primary cultured hepatocytes from freshwater Tilapia 
and induced ROS generation, as well as reduced glutathione-S-transferase (GST) and 
glutathione peroxidase (GPx) activity. After 48 hours, typical signs of apoptosis were 
observed (Liu et al., 2007b). An induction of vitellogenin production was also observed, 
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suggesting an estrogenic effect of PFOA (Liu et al., 2007a). This is supported by findings in 
an in vivo study in rare minnow, where PFOA exposure upregulated ER-β (Wei et al., 2007). 
Human exposure 
Humans are exposed to PFOA via both air, water and food. PFOA has been detected in a 
variety of food stuff (Smith, 2001; Ericson et al., 2007). The highest estimated exposure 
occurs in toddlers, who might get doses up to 128 ng/kg/d, while adults are expected to be 
exposed to 2-3 ng PFOA/kg/d. The higher exposure of children is due to the relatively higher 
food consumptions and the higher hand-to-mouth transfer of chemicals from treated furniture 
and carpets and ingestion of dust. Exposure from contaminated food and water is likely the 
most important sources, whereas house dust and consumer products contributes to a lesser 
degree. Of the consumer products, impregnation sprays, treated carpets and coated food 
contact paper are expected to be the major sources (Trudel et al., 2008).  
Health Benchmarks for chronic exposures under which no adverse effect are expected 
are 3.9 mg/kg/day for noncancer systemic toxicity, 22 mg/kg/d for developmental effects, and 
5.1 mg/kg/d for carcinogenic effects (Washburn et al., 2005). The estimated intake by Trudel 
et al. (2008) of less than 150 ng/kg/d is well below these benchmark values. Washburn et al. 
(2005) calculated Margin of exposure (MOE) values based on the benchmark values and 
estimates of daily exposure through consumer products, and found all MOEs to exceed the 
range of 100-1000 by at least a factor of 30. They concluded therefore that no adverse health 
effects are anticipated to be caused by consumer products (Washburn et al., 2005). 
PFOA-levels found in serum in the general population are around 5 ppb (Olsen et al., 
2003b; Lau et al., 2004; Emmett et al., 2006). Occupational exposure occurs in factories 
producing PFC-containing products. These workers are often exposed to much higher doses 
than the general population and the serum levels are one order of magnitude higher (Lau et 
al., 2007). Temporal trends in the levels of PFOA in human serum are inconclusive, as some 
studies find an increase (Harada et al., 2007) while others find a decrease (Olsen et al., 2007).  
 
Epidemiology  
Studies trying to relate exposure to PFCs levels in humans to different health effects are 
generally inconclusive or conflicting. In some studies of occupationally exposed individuals a 
relationship between PFOA concentration in serum and 1) cholesterol and bilirubin levels 
(Sakr et al., 2007) or 2) cholesterol, triglyceride and tyroid hormone (T3) levels are observed 
(Olsen et al., 2003a), while other studies find no correlation (Ubel et al., 1980; Gilliland and 
Mandel, 1996). 
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A retrospective cohort mortality study found an elevated prostate cancer ratio in 
production workers, with a 3.3-fold increase in prostate cancer mortality per 10 years of 
employment (Gilliland and Mandel, 1993). However, another study did not find a correlation 
between the employment time and PFOA serum concentration (Olsen et al., 2003a). A 
follow-up study divided workers into categories of likelihood of exposure and found no 
association between employment time and prostate cancer in the definitely exposed group 
(Alexander et al., 2003).  
A community exposed to higher amounts of PFOA than the general population was 
surveyed by Emmett et al. (2006). The higher exposure was due to a neighbouring industrial 
facility producing fluoropolymers and resulted in median serum levels of 350 ppb. They 
found no significant relationship between PFOA serum levels and liver or renal function, 
cholesterol, tyroid-stimulating hormone, white cell or platelet counts (Emmett et al., 2006). 
Since the average blood level was 70 times the level found in populations elsewhere, the 
authors suggest that PFOA does not influence any of the studied parameters in the general 
population. 
To investigate the reproductive effect of PFOA in humans several authors have studied 
the relationship between maternal PFOA levels and health parameters. Apelberg et al. (2007a; 
, 2007b) found a statistically significant relationship between the level of PFOA in cord blood 
with birth weight, ponderal index and head circumfence. An increase of PFOA concentration 
from the 25th to the 75th percentile was associated with a 58 g decrease in birth weight 
(Apelberg et al., 2007b). In addition, Fei et al. (2007) found that birth weight was correlated 
with PFOA concentration in maternal serum. Infants born to mothers with PFOA levels in the 
highest quartiles has an average birth weight that was ~100 g lower than infants born to 
mothers in lowest quartile (Fei et al., 2007). 
 
1.1.3 Summary PFCs 
Polyfluorinated compounds are used in a wide variety of consumer products, leading to a 
wide-spread contamination with these compounds as well as continuous exposure of humans. 
Fluorotelomer alcohols are volatile compounds, mainly found in the air. Thus, inhalation is 
the most important exposure route for these compounds. 8:2 FTOH is metabolized rapidly, 
mainly to O-glucuronides and O-sulphates, and to a lesser part to PFOA. Effects of 8:2 FTOH 
exposure include hepatocellular necrosis and peroxisomal proliferation, as well as detrimental 
effects on development in mice. In addition are both 6:2 FTOH and 8:2 FTOH suspected to 
act as xenoestrogens, so far this has only been shown in in vitro studies. PFOA is not 
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metabolized in the organism and is mainly found bound to proteins throughout the organism. 
PFOA induces peroxisomal proliferation. As a secondary effect of this, reduced body weight, 
induction of cancer in the liver, pancreas and testicle are observed. Some of the effects 
observed after PFOA exposure are though seen in PPARα-knockout mice as well. In addition, 
PFOA acts as a developmental toxicant. Exposure to PFOA occurs both by food, drinking 
water, and dust. However, exposure to both FTOHs and PFOA seems to be well below levels 
at which adverse effects on human health are expected. Nonetheless, due to large species 
differences in toxikokinetics and mode of action, it cannot be excluded that human health is 
impaired because of PFC exposure.  
 
. 
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1.2 A literature overview of a brominated compound 
1.2.1 1,2-dibromo-3-chloropropane (DBCP) 
Use and sources  
DBCP is a pesticide used as a soil fumigant against nematodes since 1955. It was sold under 
the names Fumazone and Nemagon and has been widely used on citrus fruits, grapes, 
pineapples, peaches, tomatoes, banana palm trees and soybeans (Whorton and Foliart, 1983; 
ATSDR, 1992). DBCP is applied by metering into the ground or by adding to the irrigation 
water, it then volatilizes and fumigates the soil. In 1969 over four million kg of DBCP were 
produced in the USA (Jones et al., 1979), while the annual use worldwide was estimated to 
14.7 million kg DBCP prior to the ban in 1979 (ATSDR, 1992). DBCP has a vapour pressure 
of 0.58mm Hg at 20 °C, a melting point of 6°C and a boiling point of 196°C (reviewed in 
Rice (1999)) (figure 4). 
 
Figure 4: Chemical structure of 1,2-dibromo-3-chloropropane (DBCP) 
DBCP is one of the few chemicals that has conclusively been shown to reduce fertility or 
cause sterility in humans (Whorton et al., 1977; Whorton and Foliart, 1983). The first report 
of the toxicity of DBCP was published in 1961 (Torkelson et al., 1961), and the following 
signs of toxicity were reported in rats, rabbits and guinea pigs: 
• irritation to the eyes and the respiratory tract 
• necrosis of the skin after repeated application 
• depression of the central nervous system 
• damage to the kidney  
• severe atrophy and degeneration of the testis in guinea pigs, rabbits and rats 
• reduction in testicular weight 
• reduction of spermatogenesis 
• development of abnormal sperm 
 
Torkelsen therefore suggested that “a close observation of the health of people exposed to this 
compound should be maintained” (Torkelson et al., 1961). This advice was obviously not 
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followed, since the first report of effects in humans were made by the workers themselves 
after observing that very few of them had fathered a child since they started working with 
DBCP. A survey of these men revealed azoospermia, oligospermia, raised levels of follicle 
stimulating hormone (FSH) and reduced levels of lutenizing hormone (LH) (Whorton et al., 
1977). Whorton and co-workers concluded that “although the connection has not been proved 
beyond doubt, the cause in these cases seems to be exposure to the nematocide, 1,2-dibromo-
3-chloropropane (DBCP)”. DBCP was banned in 1979 in the USA due to sterility observed in 
production workers. In some developing countries, it has been used until the 1980s (Thrupp, 
1991) and it might still be in use in some places today.  
Toxicokinetics 
DBCP is absorbed after oral, dermal and respiratory administration, and is quite rapidly 
eliminated with a half-life of 2.37 hours in the rat; the main elimination route of the 
metabolites is through the urine (Gingell et al., 1987). Låg et al. (1989a) found that the 
concentration of DBCP was higher in the testicle than in plasma. 
DBCP can be metabolized via two different pathways: via P450 enzymes or by a 
glutathione (GSH) S-transferase dependent pathway (Søderlund et al., 1995) (figure 5). In the 
liver, the cytochrome P-450 dependent pathway leads to the formation of 2-bromoacrolein (2-
BA) by oxidation of either C-1 or C-3 (Omichinski et al., 1988b). 2-BA is a potent direct-
acting mutagenic compound (Segall et al., 1985). As can be seen in figure 5 both the P450-
dependent pathway as well as the GST-pathway can lead to reactive epoxide ions which are 
electrophilic and can form adducts with macromolecules such as DNA. DBCP has been found 
to bind covalently to DNA (Omichinski et al., 1988a). Humphreys et al. (1991) suggest that 
the episulfonium ion intermediates form adducts at the N7-guanine. They also propose that 
DBCP might be able to induce intrastrand cross-links by reacting with two guanines. 
However, they report results pointing both towards guanine-guanine links, but also results 
arguing against the formation of a great number of intrastrand cross-links (Humphreys et al., 
1991). The formation of an adduct at the N7-guanine position leads most likely to an unstable 
adduct, as described in section 1.3.1. 
The GSH-dependent pathway is expected to be more important in testicular cells than 
the P450-dependent pathway (Søderlund et al., 1988). This theory was supported by the 
finding that a depletion of cellular GSH blocked the formation of DBCP-metabolites bound to 
macromolecules as well as the induction of single strand DNA breaks in rat testicular cells 
(Omichinski et al., 1988a). The levels of GSH S-transferase (GST) activity is higher in rat 
testicular tissue than in human testis (Dibiasio et al., 1991), suggesting that the GST pathway 
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is more important in rat testicular cells. The amount of GST has been shown to increase 
during spermatogenic cell development (Grosshans and Calvin, 1985), this will most likely 
lead to a higher bioactivation rate in later stages of spermatogenesis and thereby higher levels 
of DNA damage. Bauche et al. (1994) have reported high levels of both GSH and GST in 
Sertoli cells, while they observed high GSH levels combined with low GST levels in 
spermatids. 
Toxicity 
General toxicity 
DBCP is acutely toxic and the LD50 values for different species are shown in table 4. DBCP 
acts as a mutagen and clastogen; it induces base-substitutions, but no frameshift mutations 
(Rosenkranz, 1975). It is a tumor initiator, but not a complete carcinogen for mouse skin (Van 
Duuren et al., 1979). DBCP has been shown to induce DNA damage in a number of cell types 
including rat hepatocytes, Chinese hamster cells, rabbit lung cells, human leukaemia cells, pig 
kidney, rat testicular cells, rat liver cells and human renal proximal tubular cells (Brunborg et 
al., 1988; Holme et al., 1991; Søderlund et al., 1991; Becher et al., 1993; Brunborg et al., 
1996; Wiger et al., 1998). The carcinogenic effect of DBCP is probably caused by its 
genotoxic effect, most likely by forming adducts with DNA. This theory is supported by 
positive tests for mutagenicity and findings of DNA damage at the site of the tumour. Several 
research groups report DNA damage after DBCP exposure. For instance, Brunborg et al. 
(1988) found a dose- and time-dependent induction of DNA damage in rat testicular cells 
after DBCP exposure. DNA damage is also observed in the foetus of exposed dam (Brunborg 
et al., 1996).  In laboratory animals, an increased incidence rates of cancer in the following 
organs has been observed after exposure to DBCP: forestomach, mammary glands, nasal 
cavity, nasal turbinate, tongue, pharynx, adrenal gland, tunica vaginalis, epididymis, cervical 
node, ovary, skin, lung, spleen, liver, pancreas, kidney (NCI, 1977; NTP, 1982). DBCP is also 
a potent renal toxicant causing renal necrosis (Kluwe, 1981), has a plasma membrane 
damaging effect (Omichinski et al., 1987) and inhibits mitochondrial metabolism (Greenwell 
et al., 1987). DBCP is classified as followes: 
• Carcinogen (Car2b, R45: May cause cancer) (IARC, 1999) 
• Mutagen (Mut2, R46: May cause heritable genetic damage) 
• Reproductive toxic (Repr1, R60: May impair fertility) 
• Toxic (T, R25: Toxic if swallowed) 
• Irritating (Xn, R20/22: Harmful by inhalation and if swallowed) (SFT, 2008b). 
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Figure 5: Metabolism of DBCP as proposed by Søderlund et al. (1995). Reactive metabolites are shown in 
open brackets and identified GSH-conjugated in closed brackets. 
 
 
Table 4: LD 50 values for DBCP for different species and routes of administration 
Administration 
route 
Species LD 50 Reference 
Oral Guinea pig 316 mg/kg (Whorton and Foliart, 1983) 
Oral Rat 350 mg/kg (Whorton and Foliart, 1983) 
Oral Rabbit 440 mg/kg (Whorton and Foliart, 1983) 
Oral Rat 300 mg/kg (Torkelson et al., 1961) 
Oral Mouse 410 mg(kg (Torkelson et al., 1961) 
Oral  Guinea Pig 210 mg/kg (Torkelson et al., 1961) 
Oral Rabbit 180 mg/kg (Torkelson et al., 1961) 
Oral Chicken 60 mg/kg (Torkelson et al., 1961) 
Oral Prepubertal 
mice 
180.7 mg/kg (Lee and Suzuki, 1979) 
Oral Adult mice 123 mg/kg (Lee and Suzuki, 1979) 
Dermal Rat 1.4 g/kg (Torkelson et al., 1961) 
Inhalation Rat 1 hour: 369 ppm 
2 hours: 232 ppm 
8 hours: 103 ppm 
(Torkelson et al., 1961) 
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Toxicological effects on the male reproductive system 
DBCP reduces fertility in laboratory animals and severely damages testicular cells. A dose of 
60 mg/kg led to mild and reversible damage to the seminiferous tubules of rats (Shemi et al., 
1982). DBCP reduces lactate production by Sertoli cells and Leydig cell function by acting as 
an antiandrogen (Miller et al., 1985). No effects were observed in offspring of DBCP treated 
rats (Warren et al., 1984). The authors suggest therefore that the sperm capable of fertilizing 
does not contain any DNA damage. 
Several research groups report DNA damage in testicular cells after DBCP exposure 
(Brunborg et al., 1988; Søderlund et al., 1988; Låg et al., 1989b; Bjørge et al., 1996; Labaj et 
al., 2005). Brunborg et al. (1988) report a dose- and time-dependent induction of DNA 
damage in rat testicular cells after DBCP exposure. Effects after DBCP exposure of testicular 
cells occur at different doses; reduced mitochondrial function at 250 µM (Greenwell et al., 
1987; Bjørge et al., 1995), altered Sertoli function at 300 µM (Bjørge et al., 1995), and DNA 
damage at 10 µM (Bjørge et al., 1995). Since DNA damage is the outcome detected at the 
lowest concentration, it is assumed to be the crucial effect. 
The effect of DBCP on male fertility has been found to differ between species and 
between cell types. It is also dependent on the developmental stage of the organism at the time 
of exposure. 
The most sensitive species regarding the detrimental effect of DBCP on male fertility 
is the rabbit, followed by the rat and the guinea pig (Låg et al., 1989b). The least sensitive are 
mice and hamster (Foote et al., 1986). A single dose of 40 mg DBCP/kg lead to testicular 
necrosis and atrophy in rats and guinea pigs, while 120 mg/kg induced only minor damage in 
mice and none in hamster. The same susceptibility of testicular cells from these species was 
observed with respect to DNA damage after in vitro exposure (Låg et al., 1989b). Låg et al. 
suggest therefore DNA damage to be the initial event in testicular necrosis. When testicular 
cells from rats were compared to cells from human testis biopsies, short time exposure (30 
minutes, 3-300 µM) lead to a distinctive increase in DNA damage only in cells from rats, but 
not in those from humans (Bjørge et al., 1996). Also, the rate of formation of active 
metabolites was three-fold higher in rats compared to humans.  
Different testicular cells have different susceptibility towards DNA damage induced 
by DBCP, but there seems to be no consensus on which cell types are the most sensitive. 
Bjørge et al. (1995; , 1997a) found round spermatids to be the most sensitive, followed by 
spermatocytes and elongated spermatids. Amann and Berndtson (1986) suggest that 
spermatogonia and spermatocytes are the testicular cell types that are most susceptible to 
damage caused by DBCP. Lee and Suzuki (1979) found significant unscheduled DNA 
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synthesis in premiotic germ cells, but not in spermatozoa after exposure to DBCP. However, 
UDS does not measure induced damage, but repair of the lesions. Meistrich et al. (2003) 
found seminiferous tubules of exposed LBFN1 rats containing no differentiating germ cells, 
but proliferating and dividing type A spermatogonia. These spermatogonia did not undergo 
differentiation, but apoptosis, thus suggesting that the oligospermia is not due to a loss of 
stem cells, but due to a block in differentiation (Meistrich et al., 2003). 
Additionally, some stages of development seem to be more susceptible; the effect on 
the reproductive system was larger when neonatal or adult rats were exposed, than when 
adolescent rats received the same dose (Kluwe et al., 1985; Saegusa, 1987).  
 
Human exposure 
Prior to the ban of DBCP, residues of DBCP were found in several crops. However, the 
contamination of food today is believed to be minimal, and in 1986 no residues were found in 
any of over 200 tested foodstuff (Daft, 1989). In areas where DBCP has been used in large 
amounts like the California’s Central Valley and pineapple growing regions in Hawaii, 
contamination of the groundwater can still be found (Cohen, 1996; Barbash and Resek, 1997). 
This is due to the long half-life of DBCP in groundwater (about 140 years) (Burlinson et al., 
1982). The US EPA has set the Maximum Contaminant Level (MCL) for DBCP in drinking 
water to 0.2 ppb (0.2µg/l) (EPA, 2002). In addition several states have set guidelines for 
DBCP content in drinking water, with values reaching from 0.025 ppb (Arizona and 
Wisconsin) to 0.3 ppb (Minnesota) (Rice, 1999). In surveys done in 1996 in California, DBCP 
concentrations in drinking water exceeded these guidelines (Cohen, 1996; Kloos, 1996). 
Wong et al. (1988) estimated the dose received via the drinking water in California to be far 
below the dose associated with infertility in workplace settings and found no signs of reduced 
fertility in the community studied. Giardino and Andelman (1996) estimated the exposure of 
DBCP when taking a shower and found that 20% of DBCP in the 40 °C water would vaporize 
and that the time spent in the shower was proportional to DBCP exposure (Giardino and 
Andelman, 1996). When DBCP was in use, workers in manufacturing plants, as well as 
applicators and farmers were heavily exposed, but since DBCP is not in use anymore, 
occupational exposure is today limited to researchers working with DBCP. Due to preventive 
measures, as working in closed hoods, this exposure is expected to be negligible.  
Epidemiology 
As mentioned previously, DBCP is one of the few chemicals that has conclusively been 
shown to reduce fertility or cause permanent or temporary sterility in humans (Whorton et al., 
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1977; Whorton and Foliart, 1983). Workers who had been exposed to DBCP showed 
oligospermia, azoospermia, and elevated levels of follicle stimulating hormone (FSH) and 
luteinizing hormone (LH) (Whorton et al., 1977). Those who had been exposed for a long 
time, did not regain fertility even after 8 years (Potashnik and Yanai-Inbar, 1987). However, 
those who did regain fertility produced healthy offspring. Kharrazi et al. (1980) surveyed the 
pregnancy outcome of wives of DBCP exposed men. They found an increased rate of 
spontaneous abortion (Kharrazi et al., 1980), while others do not report any increase 
(Goldsmith et al., 1984). Goldsmith et al. (1984) did, however, find a decrease in the 
male:female ratio in the offspring, suggesting that Y chromosome-bearing sperm cells may be 
more susceptible to DBCP. 
In individuals who had reduced fertility the seminiferous tubules seemed to be the site 
of damage. An increased proportion of Sertoli cells is observed in individuals exposed to 
DBCP for longer periods, while seminiferous tubules were devoid of spermatogonia (Biava et 
al., 1978). This suggests that spermatogonia are the most sensitive cell type to DBCP. In 
some heavily exposed individuals, Sertoli cells were the only cells found in seminiferous 
tubules (Biava et al., 1978; Potashnik and Yanai-Inbar, 1987). 
Hofmann et al. (2006) studied the mortality amongst people who worked on banana 
plantations in Costa Rica between 1972 and 1979. They found a significant increase in 
septicaemia and nonsignificant increase in mortality from testicular cancer, penile cancer, 
Hodgins disease and Parkinson’s disease in men. Another research group examined the 
incidence of cancer in workers from banana plantations in Costa Rica and found an increased 
standardized incidence rate (SIR) for melanoma and penile cancer (Wesseling et al., 1996). 
 
1.2.2 Summary DBCP 
DBCP is absorbed both orally and dermally and metabolized to several reactive compounds. 
The bioactivation by P450 enzymes is likely most important in the liver, while activation by 
GST is important in extrahapatic tissue. GSH conjugation leads to the formation of an 
episulfonium ion, which can attack DNA, causing DNA damage. The most severe effects 
after DBCP exposure are renal failure and impaired fertility in men, both effects are likely due 
to the DNA damaging effect of DBCP. DBCP is most likely not in use anymore, but due to 
the compound being persistent in groundwater deposits, it can still be found in drinking water 
in some areas. Nonetheless, the exposure of the general population is likely low and not 
posing harm to human health.  
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1.3 Testicular cells 
The male reproductive system consists of 
• the testis 
• the external genitalia: penis and scrotum 
• the internal genitalia: accessory glands and ducts 
 
The testis is divided into approximately 250 lobule testis by the septula testis. Each lobules 
contains 1-4 tubuli seminiferi with connective tissue, blood vessels, nerves and intestinal cells 
as Leydig cells in between (figure 6). Each seminiferous tubule is 30-70 cm in length and 
contains Sertoli cells and germ cells. The seminiferous tubule merge into tubuli recti 
(epididymis) and then into the ductulus deferens, also known as vas deferens, from where 
sperm cells are transported to the urethra (reviewed in Junqueira and Carneirom, 1996). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Schematic presentation of the testis (Silverthorn and Ober, 2007) 
 
The seminiferous tubule is divided into two parts: the basal compartment and the adluminal 
compartment. The basal compartment contains the basement membranes, type-A 
spermatogonia and B-spermatogonia, as well as Sertoli cells. Sertoli cells have several tasks: 
they supply the differentiating germ cells with nutrients, they produce proteins such as 
enzymes and androgen-binding protein (ABP), they phagocyte remnants from developing 
spermatocytes, and shield the cells from endogenous and exogenous attack. The protective 
effect is mediated by the blood-testis barrier (BTB). The BTB consists of a an efflux-pump 
barrier, an immunological barrier, consisting of Fas ligands on Sertoli cells, and a mechanical 
barrier, formed by the tight junctions between Sertoli cells and the capillary endothelial cells 
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(reviewed by Bart et al., 2002). Several transporter proteins have been found be expressed in 
Sertoli cells and are therefore expected to contribute to the BTB: Mrp8, Tst1, Tst2, Ent1, 
Ent2, Mrp1, 5 and 7, Mdr2, Oatp3, Oat2, OctN2, Dmt1, Menke`s, Wilson`s, and Znt1 
(Wijinholds et al., 1998; Augustine et al., 2005). Some of these are described in more depth in 
chapter 1.5. During differentiation, primary spermatocytes penetrate the BTB and reach the 
adluminal compartment, where the later stages of spermatogenesis occur. The more 
differentiated a cell is, the closer to the luminal end of the Sertoli cell it can be found (figure 
7) (Junqueira and Carneirom, 1996). The number of differentiating germ cells is limited by 
the number of Sertoli cells, with one Sertoli cell being able to support 30-50 germ cells 
(Weber et al., 1983). Sertoli cells cease dividing when puberty is reached. Sertoli cells contain 
numerous filaments including vimentin (Franke et al., 1979). 
 
 
Figure 7: Schematic presentation of cross section of wall of a human seminiferious tubuli (Condon, 2007)  
 
Spermatogenesis is the development of spermatogonia to spermatozoa. Spermatogenesis is a 
continuous process during the reproductive phase of a male’s life. It can be divided into three 
phases: the spermatogonial phase, in which cells undergo rapid successive division, the 
meiotic phase in which genetic material is recombined and segregated, and the 
spermiogenesis phase, in which spermatids transform into spermatozoa (figure 8) (Russel et 
al., 1990). Prior to puberty, only Sertoli cells, spermatogonia and preleptotene spermatocytes 
can be found in the seminiferous tubuli. Spermatogenesis takes 74 days in humans and 52 
days in rats. It is regulated by FSH, LH and testosterone (Sutovsky and Manandhar, 2006). 
In rodents, spermatogonia can be divided into spermatogonia A and spermatogonia 
B. Spermatogonia A can commit to renewal of spermatogonia A by mitotic division, or they 
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can differentiate into spermatogonia B. Spermatogonia B then undergo spermatogenesis 
giving rise to spermatocytes, spermatids and eventually spermatozoa. Spermatogonia are 
found in the basal compartment of the seminiferious tubuli, i.e. outside of the blood-testis 
barrier (Junqueira and Carneirom, 1996). 
 
Damage to the male reproductive system 
An increase in detrimental effects on male reproduction have been observed during the past 
60 years in most European countries, but especially in Norway and Denmark (Richiardi et al., 
2004). Testicular dysfunction, anomalies and cancer has increased and semen quality has 
declined. This is probably due to environmental factors and lifestyle factors. The detrimental 
effect of these factors can be on the germ cells directly, or on the supporting cells (Leydig and 
Sertoli cells). Factors can influence these cells either directly, for instance by inducing DNA 
damage, or indirectly, for instance by influencing the hormonal system. The germinal 
epithelium of the testis is one of the most proliferative active tissues of the body and therefore 
especially susceptible to DNA damage. DNA damage in germ cells can result in apoptosis of 
spermatogonia, spermatocytes or spermatids and thereby a reduced number of sperm cells, as 
well as genetic defects in spermatozoa. Mutations in spermatozoa can lead to pregnancy loss, 
congenital malformations, mental retardation or childhood cancer, in addition to heritable 
mutations (Joel, 1966; Cohen, 1986; Colie, 1993; Cordier, 2008) (figure 9). If spermatogonia 
are damaged fertility is likely reduced permanently, while damage in spermatocytes or 
spermatids reduces fertility only temporarily. DNA damage in supporting cells like Sertoli 
and Leydig cells can lead to testicular cancer and a reduction in sperm production. 
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Figure 8: Schematic presentation of spermatogenesis. Spermatogonial stem cell, spermatogonia and later 
stages of differentiating germ cells are shown. Stippled lines indicate the position of the cell in the 
seminiferious tubuli (Olive and Cuzin, 2005). 
 
 
 
Figure 9: Possible consequences of DNA damage in germ cells (Bjørge, 1996) 
Reduced genetic quality 
of fertile sperm 
Fetal loss, malformation 
and childhood cancer 
DNA damage in germ cells 
Decreased number of 
fertile sperm 
Reduced fertility and 
sterility 
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1.4 DNA damage 
DNA consists of a sugar-phosphate backbone with four different bases attached: guanine, 
thymine, cytosine and adenine. Three hydrogen bonds are formed between guanine and 
cytosine, and two hydrogen bonds are formed between adenine and thymine. The DNA holds 
all the information necessary for the organism to develop and function properly. Damage to 
the DNA can therefore threaten cellular integrity by affecting vital processes such as 
transcription and replication, followed by changes in metabolism, cell death, and possibly 
cancer (Nelson and Cox, 2005).  
When the DNA of a cell is damaged, there are basically three possibilities: 1) the 
damage is noticed by the cell and repaired, 2) the damage is noticed and apoptosis or necrosis 
is induced, or 3) the damage is not noticed and the cell just “keeps on going”. The latter is the 
most dangerous possibility, since it can lead to alteration of protein function, altered gene 
expression, or other malfunctions as cancer development. An important distinction is between 
damage in somatic and germ cells. Many mutations in somatic cells have no effect on the 
organism as long as they do not lead to the development of cancer, while mutations in germ 
cells can have severe implications on the progeny (Pierce, 2003). DNA damage includes a 
variety of lesions spanning from base and sugar damage to DNA-protein cross-links and DNA 
breaks.  
Different mutations have diverse consequences. Point mutations are mutations in one 
single base. Here we have four different possibilities: transition, transversion, insertion and 
deletion. Transition is the replacement of a purine with a purine or of a pyrimidine with a 
pyrimidine. A transversion is the replacement of a purine with a pyrimidine or vice versa. An 
insertion is the addition of one or more nucleotides, while the remove of one or several 
nucleotides is called a deletion. Both insertion and deletion can lead to frameshifts if they 
occur in a reading frame. Frame shift mutations are especially deleterious since they often 
lead to missense mutations (reviewed in Pierce, 2003). 
The phenotypic effects of the change in the DNA can be missense, nonsense, silent 
and neutral. A missense mutation leads to the incorporation of a different amino acid into the 
protein. This can lead to a non-functional or a dysfunctional protein, but can possibly lead to a 
fully functional protein. A nonsense mutation changes a codon for an amino acid into a stop 
codon, leading to a truncated or maybe non-functional protein produced. A silent mutation is 
the change of a codon into another codon that codes for the same amino acid. Here the same 
protein is produced. An example is a change from TCG to AGC. Both code for the amino acid 
serine. A neutral mutation changes the amino acid sequence in the protein, but does not alter 
its function (reviewed in Pierce, 2003). 
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Origins of DNA-damage can either be endogenous or exogenous. Endogenous causes 
can be leakage of electrons from the electron transport chain, as well as different chemicals 
that are produced during normal cell metabolism and spontaneous errors made during 
replication (reviewed in Pierce, 2003). Also, dietary deficiencies can lead to DNA damage. 
For instance, a deficiency in foliate increases the incorporation of uracil in the DNA 
(reviewed in Friedberg et al., 2006). Exogenous factors that can induce DNA damage are 
radiation and chemicals, especially electrophilic molecules and substances producing reactive 
oxygen species. 
 
1.4.1 Types of damage 
Single and double strand break 
Radiation, oxidative damage and depurination can lead to single and double strand breaks. 
Single strand breaks (SSB) are also formed as an intermediate step during repair of DNA 
damage. Single strand breaks are often repaired correctly, while double strand breaks often 
are misrepaired and thereby lead to cell death or mutations as sister chromosome exchange 
(reviewed in Pierce, 2003). Terminally differentiated muscle cells are deprived of replication-
associated repair mechanisms, thus increasing the likelihood of persisting SSBs (Narciso et 
al., 2007). 
 
DNA adducts 
Electrophilic agents can form covalent bonds with nucleophilic sites in the DNA. One 
example is the attack of the episulfonium ion formed during metabolism of DBCP, which 
forms adducts with guanine (Humphreys et al., 1991). For the most part, adducts are formed 
with the nucleophilic groups of adenine and guanine (Cavalieri et al., 2000). Each base can 
form covalent bounds with other molecules at several sites. Depending on at which position 
on the base the adduct is formed, it can either lead to an unstable or a stable adduct (figure 
10). Unstable adducts lead to depurination. Depurination of adenine lead often to A → T 
mutations, while depurination of guanine leads to G → T mutations (Cavalieri et al., 2000). 
Stable adducts can lead to mispairing during replication, deletion, frame shift mutations and 
sister chromatid exchange (Heflich et al., 1986). In addition, stable adducts can lead to arrest 
of replication and thereby cell death. Besides, adducts can also lead to cross-linkage of DNA 
to proteins and cross-linking of two bases to each other (Van Beerendonk et al., 1992). Many 
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different adducts are removed via nucleotide excision repair (NER), as described below, since 
they are often helix distorting. 
 
 
Figure 10: Schematic presentation of a DNA strand with arrows indicating the position of adduct 
formation. White arrows indicate sites of stable adduct formation, while black arrows indicate sites where 
unstable adducts are formed, eventually leading to depurination (Cavalieri et al., 2000). 
 
Depurination 
Depurination is the loss of a purine (A or G) from the sugar-phosphate backbone of the DNA. 
This leads to an apurinic site, while loss of pyrimidine (C or T) introduces an apyrimidinic 
site. The generic term for such DNA lesions is abasic sites (AP site) (figure 11). During 
replication, a random nucleotide is incorporated opposite to the AP site; usually this is 
adenine, producing mutations. In addition, the glycosyl bond at an AP site is much more easy 
hydrolysed, producing a single strand break (reviewed in Friedberg et al., 2006). Depurination 
can occur spontaneously and as many as 10,000 purines are lost spontaneously from the DNA 
in a diploid mammalian cell in the course of 24 hours due to hydrolysis of the base-sugar 
bond (Lindahl, 1979). As described above, depurination can also occur following the 
formation of an unstable adduct, which, when breaking apart from the DNA, takes the base 
along. In addition, the formation of AP sites is a reaction intermediates during repair of DNA 
lesions.  
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Figure 11: Schematic presentation of an apurinic site (AP) (Huberman, 2006). 
Oxidative damage 
Oxidative damage is produced by reactive oxygen species (ROS); the most important being 
hydroxyl radical (OH●). ROS are the by-product of normal metabolism, mainly leakage from 
the electron transport chain (Evans et al., 1997). Other sources of ROS are phagocytosis and 
peroxisomal metabolism, as well as inflammation and iron overload (Badwey and Karnovsky, 
1986; Halliwell and Gutteridge, 2007). In addition, ROS is produced by exogenous factors 
such as chemicals and radiation. Examples of radiation that produce ROS are UV-radiation, 
X-ray, and radioactive radiation. A single γ-photon can produce some 36,000 hydroxyl 
radicals (Breen and Murphy, 1995). Chemicals that can produce ROS include metals, 
especially iron, that can undergo Fenton reaction and thereby produce OH●. Other divalent 
metals that undergo Fenton reaction include copper and chrome. Oxidative stress has been 
shown to be one of the major sources of carcinogenesis in epidemiological studies (Toyokuni, 
1996; Gilmour et al., 1997; Naito and Yoshikawa, 2005). Defence mechanisms against 
oxidative damage to cells include antioxidants like superoxide dismutase, glutathione 
peroxidase, and catalase, several vitamins, as well as repair mechanisms for induced damage. 
If an OH●-radical is formed in proximity to the DNA it can attack the DNA by 1) 
addition to the double bonds of DNA bases or 2) oxidation of a base, or 3) abstraction of 
hydrogen atoms from the deoxyribose sugar units (Cooke et al., 2003). In the latter case, base 
loss, fragmentation, and strand break can occur. Clusters of hydroxyl radicals can induce 
double strand breaks (reviewed in Pierce, 2003). 
Over 80 products of oxidative damage to DNA bases are known (reviewed in Bjelland 
and Seeberg, 2003; Cadet et al., 2003; Friedberg et al., 2006), most of which are repaired by 
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base excision repair (BER) (D`Errico et al., 2008). Guanine has the lowest redox potential 
among the bases and is therefore most readily oxidized, but attack of the C5=C6 double bond 
in pyrimidines is also quite frequent. The most studied example due to its biologically 
importance is the reaction of an OH● with the C8 position of guanine, which leads to the 
formation of 7,8-dihydro-8-oxoguanine (8-oxoG). 8-oxo-G is strongly mutagenic since it in 
the anti conformation pairs with cytosine, while the syn conformation pairs with adenine 
(figure 12), leading to CG → AT transversion (Shibutani et al., 1991; Kino and Sugiyama, 
2005). This lesion is repaired by base excision repair (BER, described below). The first step 
of the repair of 8-oxoG is the excision of the base by Fpg in bacteria and by the OGG1-DNA-
glycosylase in mammals (Barnes and Lindahl, 2004).  
 
 
Figure 12: 7,8-dihydro-8-oxoguanine shown in the anti conformation, pairing with cytosine,  
and in its syn conformation, pairing with adenine (Horvath, 2002). 
 
 
 
1.4.2 Repair of DNA damage 
More than 20,000 DNA lesions are estimated to be induced in each diploid cell during 24 
hours (Lindahl and Barnes, 2000). The cell has many repair mechanisms to prevent such 
damage from becoming mutations. The most important repair systems for exogenous induced 
DNA lesions are base excision repair (BER) and nucleotide excision repair (NER) (Lindahl 
and Wood, 1999). BER removes small DNA base lesions that do not distort the DNA helix. 
During BER a glycosylase remove the damaged base by cleaving the N-C1`-glycosylic bond, 
leaving an abasic site (AP site). An AP endonuclease cuts the phosphodiester bond, DNA 
ends are trimmed and a DNA polymerase adds a new nucleotide and the nick is sealed by 
DNA ligase (Krokan et al., 1997). Different DNA glycosylases recognize different DNA 
lesions; uracil-DNA glycosylase (UNG) cleaves erroneously incorporated uracil, while 
formamidopyrimidine-DNA-glycolase (Fpg) recognizes ring-opened purines and 8-
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oxoguanine, to mention some examples. NER removes helix distorting bulky DNA lesions by 
separating the strands, cleaving the damaged strand 5 nucleotides upstream and 21-23 
nucleotides downstream from the damage. The damaged strand is then removed, the lacking 
nucleotides are replaced by a DNA polymerase mediated process and the nick is sealed by a 
DNA ligase.  
Repair of DNA damage induced by DBCP in germ cells  
Many DNA lesions repaired in somatic cells are repaired poorly or not at all in male germ 
cells. For instance, Haines et al. (2001) detect DNA damage caused by X-ray in epididymal 
sperm 45 hours after the treatment. The different mechanisms of DNA repair have different 
activities during the different stages of germ cell development. In murines BER is an active 
repair mechanism in all stages of germ cell development, but it is likely not an active repair 
mechanism in human testicular cells (Olsen et al., 2001). A study by Jansen et al. (2001) 
indicated an active nucleotide excision repair (NER) in rat spermatocytes, but no active NER 
in round spermatids. In contrast to this, Xu et al. (2005) studied NER in mice and found a 
reduction of NER in all postmeiotic cell types, i.e. spermatids and spermatocytes. In humans 
BER has been reported to be efficient in all germ cells, while NER is not active in human 
testicular cells (Köberle et al., 1999). 
 DBCP is metabolized to an episulfonium ion which has been shown to form adducts 
with macromolecules such as DNA (Bjørge et al., 1996). Humphreys et al. (1991) suggest 
that DBCP forms an adducts at the N7-position of guanine. Bulky adducts are removed by 
NER, while smaller adducts also can be removed by BER. Lesions due to DBCP adducts are 
therefore likely repaired by both BER and NER. In early stages of spermatogenesis, both 
mechanisms are probably contributing to the repair of DBCP induced DNA damage in 
rodents. Since NER has been found to be less active in later stages of germ cell development, 
BER is likely responsible for the removal of DBCP adducts. Bjørge et al. (1997b) report that 
DNA damage induced by DBCP is repaired in spermatocytes, but not in spermatids. 
 
1.4.3 Methods to detect DNA damage and its repair 
Several methods can be used to detect DNA damage and its repair, including alkaline elution, 
unscheduled DNA synthesis, the comet assay (a k a Single cell gel electrophoresis (SCGE)), 
ELISA, micronucleus, and various chemical methods. The comet assay was chosen in the 
present study due to the high sensitivity of the assay. 
The principle used in the comet assay was first suggested by Ostling and Johanson (1984) 
and has been modified since to allow for higher sensitivity, detection of specific lesions as 
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well as higher throughput. The comet assay is used to detect DNA damage and can measure 
single and double strand breaks, as well as alkalilabile sites such as AP sites. The single 
strand breaks measured can be due to induced damage, but can also represent intermediate 
steps during DNA repair. By including repair enzymes as formamidopyrimidine-DNA-
glycolase (Fpg), specific DNA lesions can be measured. Fpg recognizes ring-opened purines 
and 8-oxoguanine and removes the oxidized base, leaving an AP site. The AP site is 
transformed into a single strand break due to the high pH used during unwinding and thereby 
measured in the comet assay. Taken together, the alkaline comet assay with Fpg can therefore 
detect  
• single and double strand breaks,  
• AP sites, which can be produced by unstable adducts or base loss,  
• specific base lesions such as oxidized purines, and 
• DNA repair intermediates. 
The idea behind the comet assay is that cells are embedded in agarose gel and lysed to remove 
membranes, proteins and cytoplasm, leaving the DNA as a nucleoid. During electrophoresis, 
broken DNA, having a negative charge, is pulled towards the anode (positively charged 
electrode), which leads to a comet-like tail (figure 13). The relative intensity of the tail 
reflects the frequency of DNA breaks. 
 
 
Figure 13: Comet images. Image A) shows a cell with very little DNA damage (approximately 5%tail-
DNA); image B) shows a cell with severe DNA damage (approximately 60%tail-DNA). Image C) shows 
several nuclei that overlap each other. Here the Perceptives software would measure three or four nuclei 
as one, resulting in an erroneous %tail-DNA. Overlapping nuclei were therefore excluded and not scored. 
 
 
B) A) C) 
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1.5 Efflux transporters 
1.5.1 General background 
Absorption, distribution, metabolism, and excretion are highly important in determining the 
toxicity of a xenobiotic. Cells have developed specialized membrane proteins to be able to 
protect themselves from harmful substances by transporting unwanted substances out of cells. 
There are several transporter families, including multi drug resistance (Mdr) proteins, such as 
P-glycoprotein (P-gp), organic anion transporters (Oat) such as Oat2, metal transporters such 
as divalent metal transporter, and multi resistance proteins (Mrp). Many of these pumps 
belong to the adenosine triphosphate (ATP)-dependent cassette (ABC) transporters, which 
hydrolyse ATP to gain the energy required for the movement of substances across the 
membrane.  
Immaculate function of the effluent pumps is required to maintain low levels of 
xenobiotics within the cell. Many amphipathic compounds can diffuse into a cell, where they 
can become conjugated, which makes them more hydrophilic so that they cannot leave the 
cell by passive diffusion. Without proper function of efflux transporters, these substances 
would accumulate in the cell (Borst et al., 2000). Inhibition of ABC transporters can lead to 
increased toxicity of harmful substances, also known as chemosensitization (figure 14) (Epel 
et al., 2008), while overexpression can lead to resistance (Scotto and Johnson, 2001). 
Chemosensitization increases the effective dose of drugs and other xenobiotics. Resistance to 
anticancer drugs has been shown to be related to increased expression of efflux pumps, 
especially P-gp, which reduce accumulation of the drug in cancer cells (Juliano and Ling, 
1976). Efflux pumps are also thought to be important in the clearance of hormone metabolites 
and other metabolic waste from the cell. Inhibition of the transporters can therefore possibly 
lead to hormonal disequilibrium. ABC transporters are found in a wide range of tissues 
important for absorption, metabolism and excretion, as well as at the blood-brain-barrier 
(BBB) and the blood-testis-barrier (BTB) (Juliano and Ling, 1976).  
The expression of selected effluent transporters is studied in this project because 
inhibition of P-glycoprotein has been shown in mussel cells after exposure to PFOA 
(Stevenson et al., 2006). 
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Figure 14: Two scenarios of transporter function in a cell. Scenario 1 shows the normal situation with all 
transporters working properly. Toxicants are either emitted immediately or after metabolism (oxidation 
or conjugation). Scenario 2 shows chemosensitization, where the chemosensitizers block the proper 
function of the transporters, leading to increased amounts of toxic substances inside the cell (Epel et al., 
2008). 
1.5.1.1 Breast cancer resistance protein (Bcrp1) 
The breast cancer resistance protein (Bcrp1, Abcg2) is a membrane protein that belongs to the 
ABCG-transporter family. It is also known as the Mitoxantrone Resistance Protein (MXR) 
and as the placenta specific ABC-protein. Bcrp1 is a 655-amino acid-spanning ATP-binding 
cassette half transporter. It consists of a single hydrophobic membrane spanning domain 
(MSD) with 6 transmembrane regions, which is preceded by a single nucleotide binding 
domain (NBD) (Doyle et al., 1998) (figure 15). The NBD binds and hydrolyses ATP to 
provide energy for the movements of substrates across the membranes (Doyle et al., 1998).  
Bcrp1 is involved in the transport of sulphate and glucoronide conjugated organic 
anions, estrone 3-sulfate and 17β-estradiol 3-sulfate, and phase II metabolites of 
benzo[a]pyren (Imai et al., 2003; Ebert et al., 2005).  
The expression of Bcrp1 seems to be dependent on the aryl hydrocarbonreceptor 
(AhR) and it is inducible by AhR ligands such as TCDD and PAHs, as well as 
anticarcinogenic phytochemicals (Ebert et al., 2005; Ebert et al., 2007). Estrogen agonists and 
antiestrogens were found to have a potent BCRP1 antagonistic activity (Sugimoto et al., 
2003). 
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Bcrp1 is among others expressed in the colon, small intestines, kidney, liver and 
placenta in humans, as well as in stem cells in mouse testis (Doyle and Ross, 2003; Lassalle et 
al., 2004; Leslie et al., 2005). Furthermore, Bcrp1 is highly expressed in the mammary gland 
during pregnancy, possibly playing a role in translocation of essential compounds as 
riboflavin into the breast milk (van Herwaarden et al., 2007). It is further reported that Bcrp1 
limits the penetration of phytoestrogens into the testis, shielding the testis from the estrogenic 
effect of these compounds (Enokizono et al., 2007). In the human blood-testis barrier Bcrp1 is 
strongly expressed on the apical side of myoid cells and on the luminal side of the capillary 
endothelial cells (Bart et al., 2004). In testicular tumour cells, Bcrp1 is more strongly 
expressed in newly formed vessels than in normal testicular tissue, which can result in 
resistance towards anticancer drugs (Bart et al., 2004).  
The murine form is quite similar to the human BCRP1: they share 81% amino acid 
identity (Allen and Schinkel, 2002). Human BCRP1 is mapped to chromosome 4q22 and is 
regulated by a TATA-less promoter in humans, while it is found on chromosome 6 in mice 
(Allen et al., 1999; Doyle and Ross, 2003). 
 
 
 
Figure 15: Predicted secondary structure of Bcrp1 (ABCG2). MSD: membrane spanning domain; NBD: 
nucleotide binding domain (Allen et al., 1999) 
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1.5.1.2 P-glycoprotein 
P-gp (Mdr1, Abcb1) is relatively non-specific with respect to its substrates; it transports 
mainly lipophilic substrates, but also amphipathic compounds. It is expressed in many tissues, 
with high levels in the ileum, the blood-brain barrier, the kidney urinary collecting ducts, at 
the luminal surface of the capillary endothelial cells of testis capillaries, and at somehow 
lower levels in Sertoli cells (Wijinholds et al., 1998; Choo et al., 2000). P-gp is not expressed 
in mitotic and meiotic germ cells, but in spermatozoa (Melaine et al., 2002). Inhibition of the 
P-gp transporter after PFOA exposure has been shown in mussel gill tissue most likely via an 
effect on the plasma membrane (Stevenson et al., 2006). However, PFOA is not a substrate 
transported by P-gp, since co-exposure with Verapamil, an inhibitor of P-gp, does not 
enhance PFOA accumulation in mussel cells (Stevenson et al., 2006). The inhibitory effect of 
PFOA on P-gp in mussel cells lead to the decision to evaluate the expression of P-gp in 
testicular cells after PFOA exposure in this thesis. 
 
1.5.1.3 Organic anion transporters 
Organic anion transporters (Oats) are expressed in the kidney, liver, brain, and placenta 
(Sekine et al., 2000). Oats transport organic anions: substances possessing a carbon backbone 
and a net negative charge at physiological pH. Therefore, it can be assumed that Oats 
transport PFOA. Oats consist of a 12-transmembrane domain structure (Burckhardt and 
Wolff, 2000). Oat2 was previously called novel liver transporter (NLT) (Simonson et al., 
1994). It is predominantly expressed in the liver, with weak expression in the kidney (Sekine 
et al., 1998; Sekine et al., 2000). However, the expression of Oat2 in the kidney of female rats 
has been found to be 7.5 times higher than in male rats (Kudo et al., 2002). Oat2 is expressed 
mainly in the sinusoidal membrane of hepatocytes, suggesting a role in the uptake of organic 
anions from the blood into the hepatocytes (Simonson et al., 1994). Oat 2 has also been 
shown to be expressed in testicular cells and in Sertoli cells (Augustine et al., 2005).  
 In the rat, PFOA is mainly excreted in the urine, and the excretion is presumed to be 
mediated by Oats. The renal clearance of PFOA is vastly different in male and female rats, as 
is the expression of Oats; PFOA is excreted 75 times faster in females, who also show higher 
mRNA levels of Oat2. Castration of male rats increased PFOA elimination, along with an 
increase in Oat2 expression (Kudo et al., 2002). An association with Oat3 was also found. 
Taken together, the results by Kudo et al. (2002) suggest that Oat2 and Oat3 are responsible 
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for the urinary excretion of PFOA. Oat1 and Oat3 have been shown to be inhibited after 
exposure to PFOA (Hagenbuch, 2008), but the effect on Oat2 has not been examined. 
 
1.5.2 Methods to evaluate gene expression 
To evaluate whether the expression of a gene is changed, several methods can be exploited. 
One can either evaluate gene expression by micro-array, end-point PCR or real-time PCR; or 
the amount of protein can be measured by immunological methods like Western blotting, or 
immunostaining and flow cytometry. 
Real-time polymerase chain reaction (real-time PCR) was developed by Higuchi et al. 
(1992) and is a sensitive method for the analysis of gene expression. RNA is isolated from 
cells or tissue and cDNA is synthesised. A master mix, containing a fluorescence marker, for 
instance SYBR Green, and a heat stable polymerase, as well as primers that are 
complimentary to the gene sequence of interest, is added to the diluted cDNA. During the 
real-time PCR this mixture is heated and cooled several times, allowing the primers to anneal 
and the polymerase to elongate the sequence. SYBR Green binds to the double stranded helix 
and emits fluorescence which is measured after each round of warming and cooling. During 
the following heating the two strands partition. Fluorescence is detected during each cycle 
and, as long as no component has become limiting to the polymerization process, the amount 
of DNA strands will double each cycle, leading to an exponential increase of the detected 
fluorescence signal. A threshold value is determined and the number of rounds a sample needs 
to cross this threshold value is measured (figure 16 A). This value is called the CT (threshold 
cycle) value for this sample. How quickly a sample reaches this threshold depends on the 
amount of cDNA for the specific gene sequence in the original sample. It is therefore an 
estimate of the amount of RNA in the cells or tissue. The CT value is then normalized relative 
to a housekeeping gene, giving a ∆CT-value. The housekeeping gene is used as an internal 
control for the PCR. The ∆∆CT-value is calculated by subtracting the ∆CT-value for the 
exposed sample from the control sample. The 2-∆∆CT-value gives a fold-change of the gene 
expression normalized to the housekeeping gene and the untreated control (Livak and 
Schmittgen, 2001). This method is based on the following calculations: 
 
The threshold value (CT) is measured during the exponential phase of the real-time PCR. The 
exponential increase is described by the equation: 
n
xn EXX )1(0 +×=  
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Where Xn is the number of target molecules at cycle number n, X0 is the number of target 
molecules at start of the reaction and Ex is the efficiency of target amplification. To calculate 
the number of target molecules at CT the equation becomes 
TXC
XT EXX ).1(0 ×=   for the target gene and  
TRC
RT ERR )1(0 +×=   for the reference (housekeeping) gene 
where XT and RT are the threshold number of target and reference molecules, CTX and CTR the 
threshold cycle for target and reference amplification and EX and ER the amplification 
efficiencies, respectively. Dividing these two equations gives  
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Assuming equal amplification efficiencies in both reactions (EX=ER=E), this equation 
simplifies to 
 
 
where XN = X0/R0, i.e. the amount of the target gene normalized to the reference gene and 
∆CT=CTX-CTR, i.e. the differences in CT-values for the target and the housekeeping gene, and 
K a constant. Rearrangement of this equation gives 
 
CT
N EKX
∆−+×= )1(  
 
The relative XN of one sample to another is then 
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where ∆∆CT = ∆CT1-∆CT2. Assuming an efficiency close to one (E=1) this simplifies to an 
expression for the amount of the target gene in one sample relative to the amount in another 
sample 
Fold change = CT∆∆−2  
 
This method was developed by Livak and Schmittgen (2001) and is often referred to as the 2-
∆∆CT
-method. 
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To control for primer-dimer formation, mispairing, and contamination, a melting curve 
analysis should be done after the completion of the PCR. Here, the temperature is increased 
and the fluorescence is measured as a function of temperature. As the temperature rises, 
hydrogenbonds between the double-stranded DNA molecules get disrupted. The larger the 
molecule is, the higher the melting temperature will be. At the temperature where the double-
stranded DNA separates, the fluorescence signal drops abruptly. This drop of the fluorescence 
signal is transformed to a peak in the graphical presentation of the derivate of the signal 
(figure 16 B). Primer-dimer products have lower melting temperatures, making them easily 
distinguishable from the desired PCR-product. Several peaks in the dissociating curve 
indicate several products, i.e. unspecific product formation (figure 16 C). 
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Figure 16: A) Output of a real-time PCR-run. The green line represents the threshold line. The pink line 
represents a sample with a lower CT-value than the green line. This indicates that there was more RNA of 
the gene examined in the sample represented by the pink line. B) Dissociation output showing a single 
product present in all wells. C) Dissociation output with two pikes, indicating several products, and some 
lines without peaks from wells were no product was formed. 
A) 
B) 
C) 
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1.6 Hypothesis to be tested 
 
Based on the literature study several hypotheses emerged that should be investigated in the 
practical part of this study: 
 
1. The polyfluorinated compounds are not expected to induce cytotoxicity or DNA 
damage after one hour of exposure. This hypothesis is based on findings by Martin et 
al. (2005), Stankowski et al. (2001) and Freire et al. (2008). 
2. Based on findings by Stevenson et al. (2006) the polyfluorinated compounds, 
especially PFOA, are expected to inhibit P-gp and possibly also other effluent 
transporters. This is expected to lead to increased gene expression of the transporters. 
3. DBCP is expected to induce DNA lesions in a dose-dependent manner in all testicular 
cells, as reported by Brunborg et al. (1988). Based on observations by Bjørge et al. 
(1995) the damage is expected to be less in Sertoli cells than in spermatids. Due to 
higher GST levels in later stages of spermatogenesis (Grosshans and Calvin, 1985) a 
higher bioactivation rate and therefore more DNA damage is expected in spermatids 
than spermatogonia. Thus, the following sensitivity ranking is expected: spermatids > 
spermatogonia and spermatids > Sertoli cells. 
4. The DNA lesions caused by DBCP are expected to be repaired in both spermatogonia 
and spermatids (Bjørge et al., 1997a). The repair is likely faster in spermatogonia 
compared to spermatids because of the reduced activity of repair systems in later 
stages of germ cell development (Xu et al., 2005; Matulis and Handel, 2006). 
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2. Materials and methods 
 
For a detailed list of chemicals, media and solutions see appendix 7.1 and 7.2. For a detailed 
overview of experimental design, refer to appendix 7.3. 
 
2.1 Chemicals 
1H,1H,2H,2H-Perfluoro-1-octanol (6:2 FTOH, 97% purity, USA) and 1H,1H,2H,2H-
perfluoro-1-decanol (8:2 FTOH, 97% purity, Japan) were purchased from Sigma-Aldrich. 
Perfluoro-n-octanoic acid (PFOA, >98% purity) was purchased from Wellington 
Laboratories, Ontario, Canada. DBCP (>99% purity) was kindly supplied by Dr. Sidney D. 
Nelson, University of Washington, Seattle, USA. Refer to appendix 7.4 for CAS number, 
chemical structure, and chemical name of the compounds. 
2.2 Animals 
Wistar rats (HanTac:WH) were purchased from Taconic (Denmark) and bred at the facility at 
the Norwegian Institute of Public Health (Norway) with 12 hour light/dark cycle, 6-10 air 
changes per hour, controlled humidity (55 ±5%) and temperature (19-23°C). The animals 
were given Harlan Teklad 2018E diet (Harlan, UK) and water ad libitum. The breeding cages 
contained one male together with two females. Pups were separated at the age of three weeks 
and only males were used in this study. 
 
2.3 Preparation of cell samples 
2.3.1 Preparation of testicular cells 
Testicular cells were prepared by the digestive enzymatic method, modified after Søderlund et 
al. (1988). Wistar rats of 5-8 days of age (for isolation of spermatogonia) or 6-8 weeks of age 
(for isolation of adult testicular cells) were sacrificed by CO2 asphyxia and the testicles were 
removed and placed in testicular medium added 10% FCS (see appendix 7.1 for details on 
media composition). The capsule was removed from the testicles and the tubuli were cut in 
smaller pieces and incubated in a solution of 100U/ml collagenase in testicular medium for 20 
minutes in a rotating water bath at 32 °C and 104 rpm. This step dissolves extratubular cells 
such as Leydig cells, connective tissue and blood cells. The tubuli were then allowed to 
sediment and washed twice with medium to remove the dissolved cellular fragments, as well 
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as blood. The remaining cells were incubated with 100U/ml collagenase once more in a water 
bath for 20 minutes at 32 °C and 104 rpm. Trypsin was then added to an activity of 2324 U/ml 
and this solution was incubated for another 8 minutes. This step eliminates the cell-cell-
contact, i.e. germ cells are detached from Sertoli cells, and Sertoli cells are detached from 
each other and the basal membrane. After the incubation, medium containing 10% FCS was 
added to inactivate the trypsin. After spinning at 1500 rpm for 5 minutes, the cells were 
resuspended in new medium containing 10% FCS. This washing step was repeated three 
times to deactivate the trypsin. The cells were then filtered through gaze to remove tubuli 
fragments, sperm cells, and cell debris, and then through a 100 µM and a 40 µM net. A small 
sample was stained using Trypan Blue to evaluate viability. Cells were then allowed to 
recover from the isolation process for half an hour at 32°C, 5% CO2 before exposure. The cell 
suspension from adult rats, contain several different testicular cells: primary and secondary 
spermatocytes, spermatids, Sertoli cells, and Leydig cells. The cells obtained from prepubertal 
rats consist of Sertoli cells, other somatic cells, and germ cells, of which type A 
spermatogonia are the most abundant cell type (Clermont and Perey, 1957). 
2.3.2 Purification of spermatogonia and somatic cells 
Cells from prepubertal rats (5-7 days of age) were isolated from testicular tissue as described 
above. Purification of spermatogonia was done as described by Morena et al. (1996): Cells 
were sown in plastic dishes coated with lectin and incubated at 32°C for one hour to remove 
the adhering somatic cells. During this incubation, somatic cells get attached to the lectin, 
increasing the percentage of spermatogonia in suspension. Different incubation times were 
investigated, and one hour was found to result in the highest percentage of spermatogonia. 
After one hour incubation, the suspension was removed from the lectin dishes and placed in 
bacterial dishes for exposure. An incubation time of 24 hours was found to lead to the lowest 
percentage of spermatogonia in suspension and was used to examine effects on Sertoli cells 
and other somatic cells.  
The coated plastic dishes were prepared by adding a 5 µg/ml solution of lectin in 
phosphate buffered saline (PBS), which was incubated for 1 hour at 37°C and washed off with 
0,5% BSA. The dishes were then dried and stored at room temperature before usage (Morena 
et al., 1996).  
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2.4 Vimentin staining for assessment of cell identity 
The amount of somatic cells was evaluated by staining of cells with vimentin, a cytoskeletal 
protein expressed solely in somatic cells. Spermatogonia were isolated from rat testicular cells 
as described previously. After spinning at 1500 rpm for 5 minutes, the cells were resuspended 
in PBS containing 2% PFA at a concentration of 1 million cells/ml. A small drop of this cell 
suspension (3-5 µl) was applied on a Polysine Microslide and allowed to dry. After washing 
in distilled water, the cells were incubated over night at 4°C with the primary antibody 
solution (anti-vimentin clone V9, Dako AS, Denmark) at a 1:2000 dilution in 1% BSA 
solution with 0,01% thimerosal. The next day, the cells were washed twice in PBS and dried. 
This was followed by incubation for 30 minutes with the secondary antibody (RRX anti-
mouse, Jackson Immuno Research Laboratories, PA, USA) at a dilution of 1:100 in 1% BSA 
solution with 0,01% thimerosal. The slides were then washed 3 times with PBS. Hoechst 
33258 was added to the last wash to stain the DNA. After an additional wash in water, the 
slides were dried and analysed with Olympus BX51 microscope with an Osram Mercury 
Short ARC HBO® 100W/2 light bulb. Cells stained with Hoechst and those stained with 
vimentin were counted manually and the percentage vimentin-negative cells was calculated. 
The somatic cells, such as Sertoli cells, stain positively for vimentin, so the vimentin negative 
cells are evaluated to be germ cells. No distinction could be made between spermatogonia A 
and spermatogonia B. 
 
2.5 In vitro exposure of cells  
2.5.1 Polyfluorinated compounds and DBCP 
Stock solutions of the test compounds were prepared in DMSO and stored at 4°C. Cells were 
exposed in suspension at 32 °C, 5% CO2, 20%O2 for one hour at a density of 1-2 million 
cells/ml in bacterial dishes. Testicular cells from adult rats were exposed to 0, 3, 10 and 30 
µM DBCP, while spermatogonia and somatic cells from prepubertal rats were exposed to 0, 
10, 30 and 100 µM DBCP. Exposure with the different PFCs was done with concentrations of 
0, 10, 30, 100, 200 and 300 µM. 30 µM DBCP was used as a positive control in the comet 
assay with polyfluorinated substances. The PFC doses were chosen according to results by 
Martin et al. (2005) using up to 200 µM. Control cells were exposed to 0.2% DMSO. The 
amount of DMSO was not adjusted in the other treatments. After exposure, cells were put on 
ice and washed three times with cold PBS to remove excess exposure and to inhibit repair of 
DNA damage.  
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2.5.2 X-ray experiment 
To standardize the Comet assay, experiments were performed in which cells in suspension 
were exposed to 0, 3, 6 or 10 Gy of X-ray. The cells were irradiated in eppendorf tubes placed 
directly on the X-ray tube window, with a 0.5 mm Cu film as filter. The X-ray source was a 
Phillips MG300 X-ray unit (Germany) operated at 10 mA and 260 kV. The dose rate was 10 
Gy/minute, as measured by Fricke’s chemical dosimetry. It is expected that 1Gy of X-
irradiation causes 0.31 breaks per 109 Da of cellular DNA, which is approximately 1000 
breaks per diploid mammalian cell (Ahnstroem and Erixon, 1981). The %tail-DNA increases 
linearly with break frequency over most of its range and %tail-DNA can therefore be 
converted to number of breaks/cell. 
2.5.3 Determination of repair capacity 
For the determination of the repair capacity, cells in suspension were exposed to DBCP at 
32°C, 5% CO2, 5% O2 for one hour and then extensively washed with medium containing 
10% FCS. Each cell sample was then divided into 6 subsamples and these were placed in 
bacterial dishes and incubated at 32°C, 5% CO2, 5% O2 for 0, 1, 2, 4, 8 or 24 hours. The DNA 
damage after the repair was then analysed by the Comet assay by assessing the %tail-DNA 
(described below). 
2.6 Cytotoxicity by Trypan Blue exclusion test 
After exposure and extensive washing, cells were stained with Trypan Blue and viability was 
determined by manual counting in a Buerker counting chamber. Live cells with intact 
membranes will exclude the Trypan Blue dye, while dead cells do not exclude the dye, and 
appear blue in the microscope (figure 17). The number of blue cells gives an indication of 
dead cells and thereby an indication of cytotoxicity. Approximately 80 cells in 5 different 
squares were counted from each sample in three separate experiments. 
 
 
Figure 17: Image showing living cells (white) and dead cells (blue) after staining with Trypan Blue (Qiu, 
2008) 
 
Alive cell 
Dead cell 
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2.7 The comet assay 
All solutions used in the comet assay are described in appendix 7.2. After the previously 
described exposure and wash, cells were resuspended in medium at a concentration of 2 
million cells per ml. This suspension was then mixed 1:10 with 0.75% low melting agarose at 
37°C, which was dissolved in 10mM EDTA in PBS and immediately moulded in wells on a 
cold GelBond film. Three wells were moulded from each sample, producing 3 gels per sample 
(refer to appendix 7.3 for overview of experimental design). These gels were then placed in 4 
°C lysis buffer over night. This step lyses the cells, most protein is washed out, and only 
nucleoides remain in the agarose gel. After rinsing in distilled water, the films were 
transferred to Fpg-enzyme reaction buffer and incubated for one hour at 4 °C. The buffer was 
changed after the first 10 minutes. After the incubation in cold Fpg-enzyme reaction buffer, 
half of the films were incubated in Fpg-enzyme reaction buffer with 0,2 mg/ml BSA added 1 
µg/ml Fpg crude enzyme, while the other half was incubated in Fpg-enzyme reaction buffer 
with BSA but without Fpg enzyme, all at 37 °C for one hour. The Fpg enzyme detects 
oxidative damage by transforming oxidized purines to AP sites, as well as by making an 
incision next to it. To stop the enzyme reaction and to unwind the DNA, the films were 
incubated for 5 + 35 minutes in electrophoresis buffer. The supercoiling of the DNA stand is 
relaxed during unwinding since the high pH disrupts hydrogen bonds between the double-
stranded DNA. In addition, the high pH of the buffer (13.2) leads to the transformation of 
alkalilabile sites, as AP sites, to single strand breaks. Electrophoresis was then performed in 
the same buffer at 8 °C with 20 V and 300 mA corresponding to 0,74 V/cm for 20 minutes. 
During electrophoresis, DNA loops are pulled out of the nucleoide. The more strand breaks 
exist in the DNA, the more loops can be pulled out of the nucleoide. To stop further 
unwinding, the films were placed in neutralizing solution. After fixating the gels with alcohol, 
they were dried and stored until scoring. For scoring, the DNA was stained with SYBRGold 
in TE-buffer for 20 minutes. The comets were scored using either a Leica DMLB with an 
Osram Mercury Short ARC HBO® 50W/2 light bulb, or an Olympus BX51 microscope with 
an Osram Mercury Short ARC HBO® 100W/2 light bulb. The Comet assay IV, Perceptives 
instruments software was used. The %tail-DNA was used as a measure of damage. It is a 
measure of the relative fluorescence intensity in the head and the tail, and is the suggested 
measure of DNA damage in the comet assay by the International Workshop on Genotoxicity 
Test Procedures in 2005 (Burlinson et al., 2006). The %tail-DNA increases linearly with 
break frequency, is independent of the threshold setting in the image analysis program, and 
allows measurement of damage across the widest possible range of damage (0 to 100%) 
(Collins, 2004). In each gel 50 nuclei were scored, since Smith et al. (2008) have shown that 
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an increase to 100 nuclei per gel resulted in virtually no increase in observed power of the 
statistical analysis (Smith et al., 2008). Overlapping cells were excluded from the analysis, 
since the software cannot discriminate between overlapping nuclei, leading to an incorrect 
%tailDNA. This could possibly lead to a biased sampling technique, since comets with small 
tails are less likely to overlap. However, by closely controlling the cell density in the agarose 
gels, the number of overlapping cells was minimized.  
Cellular samples obtained from adult testicles were found to contain mainly haploid 
cells, i.e. round, elongating and elongated spermatids. Only round spermatids having a round 
shaped nucleus with histone-based chromatin were analyzed in the comet assay. Both 
elongating and elongated spermatids by various degrees of sickle-shaped nuclei were omitted 
from comet analysis. Subsequently, in this report the term spermatid refers to round 
spermatids. 
 
2.8 Gene expression analysis 
2.8.1 Preparation of cells 
Cells are isolated from rat testicles and exposed to PFCs as previously described. After 
exposure, cells were washed with cold PBS. After the last centrifugation, the PBS is aspirated 
and about 4 million cells per exposure are stored at -80 °C until isolation of RNA. 
2.8.2 Isolation of RNA 
Total RNA was isolated using the SV Total RNA Isolation System kit (Promega, USA). The 
frozen cell samples were suspended in 175 µl RNA lysis solution by pipetting with a syringe. 
After adding 350 µl RNA dilution buffer, the samples were placed in a heating block at 70 °C 
for 3 minutes. Spinning at 12000x g for 10 minutes at room temperature leads to precipitation 
of proteins and salts. The supernatant was then transferred to a new tube and mixed with 200 
µl alcohol. This solution was transferred to a spin column assembly and centrifuged at 12000x 
g for one minute. The RNA on the filter in the spin column assembly was washed by adding 
600 µl RNA wash solution and spun for one minute at 12000x g. To remove DNA from the 
samples, DNase incubation mix, consisting of 5 µl DNase, 40 µl Yellow Core and 5 µl 0,09 M 
MnCl, was incubated with the RNA for 15 minutes. The process was stopped by adding 200 
µl DNase Stop Solution and centrifuging at 12000x g for one minute. DNA and DNase was 
removed by washing twice with RNA Wash Solution. The Spin basket with the RNA was 
transferred to a new tube and 100 µl nuclease-free water was added on top. After spinning for 
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one minute at 12000 g, the solution was transferred to the membrane again, and the spinning 
is repeated to elute all the RNA. The RNA content in the solution was measured using the 
Thermo Scientific NanoDropTM 1000 spectrophotometer, the RNA was aliquoted and the 
samples were stored at – 80 °C. 
2.8.3 Preparation of cDNA 
cDNA was synthesised by Reverse Transcriptase (RT) using the Reverse Transcription 
System kit (Promega, USA). The RNA sample (10µl) was mixed with 18 µl Reverse 
transcriptase buffer, 36 µl 25mM MgCl2, 18 µl 10mM dNTP, 4,5 µl Rnasin, 9 µl random 
primers and 6,75 µl AMV enzyme. cDNA synthesis was done in the eppendorf Mastercycler 
Gradient. The content of cDNA in the sample was measured by the Thermo Scientific 
NanoDropTM 1000 spectrophotometer, the cDNA was aliquoted and stored at -20°C. 
 
2.8.4 Quantitative real-time polymerase chain reaction (real-time PCR) 
The real-time PCR was used to investigate whether selected genes were up- or downreglated 
in the exposed cells compared to control cells. The effect on three genes was analyzed:  
• Bcrp1  
o forward: 5`-CAATGGGATCATGAAACCTG-3`;  
o reverse 5`-GAGGCTGGTGAATGGAGAA-3` from Kameyama et al. (2008),  
• Pgp/Mdr1b  
o forward: 5`-ACAGAAACAGAGGATCGC-3`;  
o reverse: 5`-AGAGGCACCAGTGTCACT-3`, 352 bp, from Kameyama et al. 
(2008), and  
• Oat2 (Slc22a7, SuperArray).  
A dilution experiment was performed to find the best dilution of the cDNA and to evaluate if 
the underlying assumptions as equal amplification efficiency were complied. In this dilution 
experiment the cDNA was added to the wells in 5 replicated for each dilution (1, 0.1, 0.01 and 
0.001). During subsequent experiments, 2 µl of the diluted cDNA were added in each well of 
a 96 well plate. The first experiment was carried out using a 1:100 dilution, while the second 
experiment was done with a 1:10 dilution. Each sample was analysed in 5 replicates for the 
selected gene and in 3 replicates for the housekeeping gene 18S. Specific master mix was 
prepared for each gene containing 10 µl Power Sybr Green mix (Applied Biosystem, UK), 6 
µl nuclease free water, 1 µl forward primer and 1 µ
 61 
The real-time PCR was performed on an Applied Biosystem 7500 Fast Real-Time PCR 
System with the following configuration:  
• Stage 1: 94 °C for 10 minutes. 
• Stage 2: 94 °C for 15 seconds, followed by 60°C for one minute and 72 °C for 30 
seconds. This stage was repeated for 40 cycles and the fluorescence was detected 
during the 72 °C-step. 
• Stage 3: 95°C for 15 seconds, 60 °C for one minute and 95°C for 15 seconds. 
Afterwards, a dissociation stage was run with a gradual temperature increase.  
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2.9 Statistical analysis 
Statistical analysis of cytotoxicity and DNA damage were done with SPSS v16.0. Data from 
real-time PCR were analysed in Microsoft Excel 2003 and Matlab v7.0, as well as 
SPSSv16.0. Where ANOVA was used, the three underlying assumptions had to be evaluated: 
• Mutually independence of observations 
• Normal distribution of data 
• Equal variance in each sample 
The normality of the data was evaluated using the Kolmogorov-Smirnov test. The 
homogeneity of variances was evaluated with the Levene`s test.  
 
The cytotoxicity was assessed by measuring the percentage viable cells in each square in the 
counting chamber. Cytotoxicity was evaluated in three separate experiments. The data from 
each sample were compared using an univariate ANOVA in a nested model with experiment 
number as a random factor and exposure as a fixed factor.  
 
The induced DNA damage was measured in two experiments for each compound. Although 
there is a large dataset from each experiment, since 50 nuclei in each of the three gels were 
measured, these are only technical replicates, not independent measurements. To perform 
statistical analysis, one would want at least three independent experiments, but due to time 
limits, this was not possible. The data are analyzed statistically to show possible trends in the 
dataset, but should not be thought of as conclusive statements. The data from the comet assay 
were analysed in a hierarchical model using univariate ANOVA with experimental number 
and gel number as random factors, and exposure as the fixed factor for the dependent variable 
%tailDNA. When a significant difference was found at the 0.05-level between the groups, a 
Dunnetts T3 test was used as a posthoc test. The Dunnett`s test compares the control group 
with all other groups and adjusts the error rate according to the number of comparisons made. 
The Dunnett’s T3 test is a variant of the Dunnett`s test which is appropriate when the 
variances are unequal. The analysis was also done for log transformed data. Since the %tail-
DNA can have the value 0, a small figure (0.000001) was added to all values prior to log 
transformation. 
 
The analysis of gene expression was done in two independent experiments with three 
technical replicates for the housekeeping gene and five technical replicates for Bcrp1. There is 
some disagreement as to whether the technical replicates should be treated as the experimental 
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unit or whether one needs three independent experiments before being able to perform a 
statistical analysis of real-time PCR-data. Due to time limits, it was not possible to perform a 
third experiment, but a statistical analysis is done nonetheless to look for trends in the data. 
Data from real-time PCR experiments were analyzed with several methods. To identify the 
appropriate dilution and to examine amplification efficiencies of the two genes, a logistic 
regression analysis was done with the results from the dilution experiment as suggested by 
Livak and Schmittgen (2001). This analysis was done in Microsoft Office Excel 2003.  
The ∆CT values from the exposed samples were tested against the control with the 
Student’s t-test as suggested by Yuan et al. (2006), using MatLab. Here, the technical 
replicate is used as the experimental unit and the analysis was done in each experiment 
separately. To take into consideration that data were compared several times, the p-value for 
significance was adjusted by the quite conservative Bonferroni method: αnew = αold/n = 0.05/3 
= 0.0167, where n is the number of comparisons made.  
Additionally, data were analyzed by subtracting one of the three 18S-CT-values for the 
sample from each gene-CT-value. Which of the three 18S-CT-values was subtracted was 
decided by a randomization function in Excel. The resulting ∆CT-values were analyzed by 
univariate ANOVA. Due to a lack of normality and homoscedasticity, the logtransformed 
∆CT-values were also tested. Graphical presentation of gene expression was done by the 2-
∆∆CT
 method as described by Livak and Schmittgen (2001).  
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3. Results 
Throughout this chapter, results from the different exposures are presented according to the 
following colour scheme. Cells exposed to  
• 6:2 FTOH: blue 
• 8:2 FTOH: red 
• PFOA: green 
• Adult testicular cells exposed to DBCP: pink 
• Spermatogonia exposed to DBCP: yellow 
 
3.1 Purity of cell samples 
The fraction of spermatogonia in the different cell samples isolated from 5-8 day old rats was 
evaluated according to lack of vimentin staining. The 5-8 day old rats are prepubertal, so all 
the germ cells are in the spermatogonia stage. Therefore, the cells that do not stain with 
vimentin, are considered spermatogonia. The cells isolated from prepubertal rats were found 
to contain 68% spermatogonia before the selective cultivation on lectin dishes. A time series 
of different incubation times revealed that the highest percentage of spermatogonia was 
achieved after one hour of selective cultivation in lectin coated dishes (figure 18). After one 
hour incubation, the cells in suspension consist of approximately 82% spermatogonia. At 
longer incubation times, spermatogonia were found to attach, too. They attached either to the 
lectin or to the Sertoli cells already bound to the lectin. This resulted in a lower percentage of 
spermatogonia in suspension. After 24 hours, the suspension contained 55% spermatogonia 
and 45% Sertoli and other somatic cells. Samples collected after 24 hours will nonetheless be 
referred to as “somatic cells”, although only less than half of the cells actually are Sertoli and 
other somatic cells. Testicular cells isolated from adult rats in this project were analysed by 
flow cytometry in another project in our lab (data not shown). Theses cell samples were found 
to consist mainly of haploid cells, i.e. spermatids. The remaining cells consist of equal 
amounts of diploid and tetraploid cells, i.e. primary and secondary spermatocytes, as well as 
somatic cells. 
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Figure 18: Percentage of vimentin negative cells as a function of incubation time on lectin coated dishes. 
 
 
3.2 Cytotoxicity 
 
Since all test compounds were diluted in DMSO, the effect of DMSO on cell viability was 
examined (figure 19). Because this experiment was only performed once, no statistical 
analysis of the results was done. It appears though, that the exposure to DMSO does not 
influence cell viability. 
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Figure 19: Box plot of viability of testicular cells after one hour of exposure to DMSO. Mean values with 
standard deviation are shown. 
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Figure 20: Viability of testicular cells from adult rats exposed to A) 6:2 FTOH (blue), B) 8:2 FTOH (red), 
C) PFOA (green), D) DBCP (pink) and E) viability of spermatogonia exposed to DBCP (yellow). Results 
are shown for the three experiments taken together (n=300-400 in each experiment). Shown are median 
value, interquartiles, outliers (dots) and extreme values (asterisk).  
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Cytotoxicity was tested in three separate experiments, in which 300-400 cells were evaluated. 
Viability of cells was not significantly reduced after any of the treatments in either the adult 
testicular cells or the spermatogonia (figure 20 and table 5). The results were analysed in a 
hierarchical (nested) analysis with experiment number as a random factor. The data were 
normally distributed, but the variances were not homogenous. There was no significant 
difference between the three experimental runs.  
 
Table 5: p-values from the univariate analysis of variance for the viability of cells after exposure to 6:2 
FTOH, 8:2 FTOH, PFOA or DBCP.  
 
Substance p-value 
6:2 FTOH 0.42 
8:2 FTOH 0.62 
PFOA 0.45 
DBCP  
(adult testicular cells) 
0.30 
DBCP 
(spermatogonia) 
0.64 
 
 
However, the interaction exposure*experiment-number was significant for the adult testicular 
cells exposed to DBCP, suggesting a difference between the experimental runs. To examine 
this in more depth, each experiment was analysed alone, and a significant decrease in viability 
was found in one of the three experiments (p=0.252, p=0.008 and p=0.370 for the three 
experimental runs, univariate ANOVA). A post hoc test of results from experiment number 2 
showed significant decrease in the 10 µM group (p=0.049, Dunnett`s T3) (figure 21). Since 
only one out of the three experiments showed reduction in cell viability after DBCP exposure 
at only one concentration, it is assumed that DBCP does not actually impair cell viability at 
the tested concentrations. 
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Figure 21: Viability in adult testicular cells after exposure to DBCP. Results from the three experiments 
are shown. The box plot shows the minimum, first quartile, median, third quartile and maximum of all 
measurements from the two experiments, as well as outliers. 
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3.3 DNA damage 
In this study DNA damage was measured using the comet assay, which detects single strand 
breaks, alkalilabile sites, and, due to inclusion of Fpg, oxidized purines. The data obtained by 
this method are not normally distributed and failed the normality test (Kolmogrow-Smirnov), 
as well as the test of homoscedasticity (Levene`s test). A logtransformation of the data was 
attempted, but did lead to neither normality nor homoscedasticity. The results of this approach 
together with QQ-plots of some data, can be found in appendix 7.5.1 and 7.5.3. 
 
The potential of DMSO to induce DNA damage was assessed to establish whether that the 
vehicle was responsible for significant DNA damage during exposure. Cells treated with 
DMSO did not have measurable increased DNA damage (figure 22). The difference in gels 
treated with Fpg was borderline significant (p=0.07) while the difference caused by DMSO in 
gels without Fpg treatment was far from significant (p=0.45 from a one-way ANOVA). An 
effect of DMSO on the measured DNA damage was therefore excluded. 
 
 
Figure 22: DNA damage in cells exposed to DMSO. Results are shown for both gels with and without Fpg 
treatment. The box plot shows the minimum, first quartile, median, third quartile and maximum of all 
measurements from the two experiments, as well as outliers and extreme values. 
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3.3.1 Calibration of the comet assay by X-ray 
Cells were exposed to X-ray to calibrate results from the comet assay and to investigate the 
efficiency of the comet assay to detect DNA damage in the different cells types. Adult 
testicular cells, spermatogonia, and somatic cells were exposed to 0, 3, 6, or 10 Gy and the 
induced DNA damage was measured with the comet assay. Exposure to X-ray induced 
comparable amounts of DNA damage in spermatogonia, adult testicular cells, and somatic 
cells, suggesting that the efficiency for detecting DNA damage is similar in those cell types 
(figure 23). As mentioned earlier, 1 Gy is expected to cause approximately 1000 DNA breaks 
in a diploid cell. In all cell types 3 Gy induced ~18 %tail-DNA, resulting in 166 breaks per 
%tail-DNA. A dose of 6 Gy led to ~30 %tail-DNA, which equals 200 breaks per %tail-DNA, 
while 10 Gy led to ~48%tail-DNA, implying 208 breaks per %tail-DNA. The mean-value of 
these three doses is 191 breaks/%tail-DNA. 
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Figure 23: DNA damage in spermatogonia, adult testicular cells, and somatic cells after X-ray exposure. 
The means of the three medians from each gel are shown.  
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3.3.2 Polyfluorinated compounds  
The amount of induced DNA damage in testicular cells from adult rats after exposure to 6:2 
FTOH, 8:2 FTOH, and PFOA was examined. No marked trend in DNA damage was 
observed. Figure 24 shows the %tail-DNA as a function of exposure to the different 
polyfluorinated substances. The DNA damage was found to be slightly higher in cells treated 
with Fpg compared to cells not receiving Fpg-treatment. Figure 24 shows only values for the 
cells treated with Fpg, while data from cells without Fpg-treatment can be found in the 
appendix 7.5.2  
The %tail-DNA was not significantly increased in testicular cells from adult rats after 
exposure to 6:2 FTOH, 8:2 FTOH, or PFOA, at concentrations up to 300 µM (table 6). 
However, as can be seen in table 6, the observed power of the statistical analysis was low. A 
power >0.8 is normally considered adequate. The lower power observed in this post hoc 
power analysis indicates that one might not reject a false null hypothesis. In addition, there 
was great variation in %tail-DNA values with many outliers, as can be seen in figure 24. 
Nonetheless, it can be assumed that no measurable DNA damage was induced in the testicular 
cells after one hour of exposure to the polyfluorinated substances.  
 
Table 6: F- and p-values from the nested univariate ANOVA of %tail-DNA of cells exposed to 6:2 FTOH, 
8:2 FTOH or PFOA, together with the observed power. 
 
Compound p-value F-value Observed power 
6:2 FTOH 0.77 3.480 0.566 
8:2 FTOH 0.549 1.221 0.088 
PFOA 0.329 2.548 0.147 
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Figure 24: DNA damage as expressed by %tailDNA in adult testicular cells exposed to A) 6:2 FTOH 
(blue), B) 8:2 FTOH (red), and C) PFOA (green). No significant increase in %tail-DNA was observed. 
Shown are values with Fpg-treatment. The box plot shows the minimum, first quartile, median, third 
quartile and maximum of all measurements from the two experiments. The circles represents outliers (> 
1.5 x IQR) and asterix (*) represent extreme points (> 3 x IQR).  
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3.3.3 Dibromochloropropane (DBCP) 
The induction of DNA damage following DBCP exposure was investigated in three cell types: 
adult testicular cells, spermatogonia and somatic cells. The highest level of DNA damage was 
found in somatic cells, followed by adult testicular cells. Spermatogonia showed the least 
DNA damage (figure 25). 
One of the goals was to examine the susceptibility to DNA damage induced by DBCP 
in the different testicular cell types. As mentioned before, the somatic cell samples are 
composed of 45% Sertoli cells and 55% spermatogonia. The results obtained in the comet 
assay were used as an indication of the susceptibility of Sertoli cells, but due to the poor 
purity not analyzed statistically. The results show a trend towards higher susceptibility of 
Sertoli cells to DBCP compared to both adult testicular cells and spermatogonia (figure 25).  
Data from adult testicular cells and spermatogonia were analyzed statistically. The 
%tail-DNA was significantly increased in both adult testicular cells (F=86.849, p<0.001, 
univariate ANOVA) and in spermatogonia (F=90.652, p<0.001, univariate ANOVA). The 
post hoc test showed that all the DNA damage was increased at all concentrations relative to 
the control (p<0.001, Dunnett`s T3), except for adult testicular cells exposed to 3 µM DBCP 
(p=0.122, Dunnett`s T3). Therefore, a fit of the data to a dose-response model was attempted. 
The models with the best fit can be found in the appendix. However, due to poor fit to the 
models (R2<0.5), this approach was abolished. For graphic representation of the models, refer 
to appendix 7.5.4.  
The level of induced DNA damage was generally lower in spermatogonia compared to 
adult testicular cells. This difference was especially marked in cells not treated with Fpg, 
where the response at both 10 µM and 30 µM was significantly different in the two cell types 
(p<0.001). Exposure to 30 µM DBCP led to ~20%tail-DNA (≈3820 DNA breaks/cell) in 
spermatogonia, while the same concentration induces ~50%tail-DNA (≈ 9550 DNA 
breaks/cell) in adult testicular cells. DNA damage measured in cells not treated with Fpg 
shows strand breaks and alkalilabile sites, while Fpg treatment also reveals oxidized purines. 
The amount of net Fpg-sensitive sites is much higher in spermatogonia, suggesting that 
spermatogonia are more prone to oxidative DNA damage than adult testicular cells. 
Taken together these results suggest that DBCP causes DNA damage in all tested cell 
samples. Further on, spermatogonia seem to be more resistant to strand breaks and alkalilabile 
sites caused by DBCP exposure than adult testicular cells, while the sensitivity towards 
oxidized purines is higher in spermatogonia. The somatic cell population showed the highest 
susceptibility towards DNA damage. 
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Figure 25: DNA damage as expressed by %tailDNA in adult testicular cells exposed to DBCP (top panel, 
pink), in spermatogonia (yellow), and in somatic cells (orange, bottom panel). The left column shows 
values without Fpg treatment, while the right column shows measurements from gels treated with Fpg 
(striped bars). Note the different exposure concentrations used in adult testicular cells. The box plot shows 
the minimum, first quartile, median, third quartile and maximum of all measurements from the two 
experiments, as well as outliers and extreme values.  
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3.3.4 Repair capacity of DBCP induced DNA damage  
The repair capacity was evaluated using the comet assay in two separate experiments for each 
cell type. Unfortunately, only one experiment per cell type gave satisfactory results, the other 
showing very high background levels of DNA damage and less DNA damage than expected 
in treated cells. One of the possible reasons here is the use of an old batch of diluted DBCP 
which had been frozen and thawed many times, so a new batch was prepared for the second 
round of experiments, giving better results.  
Cells treated with Fpg showed no reduction in %tail-DNA during 24 hours (appendix 
7.5.5), suggesting no repair of oxidative DNA damage or constant induction of new oxidative 
damage. However, cells without Fpg-treatment showed reduction in %tail-DNA, implying 
that strand breaks and alkalilabile sites were repaired.  
No clear difference in repair capacity of DBCP-induced damage was found between 
adult testicular cells and spermatogonia (figure 26). The repair after an exposure causing 
approximately 60%tail-DNA (≈11460 breaks/cell) in the cells without Fpg-treatment was 
analyzed in more depth (adult testicular cells exposed to 30 µM, spermatogonia exposed to 
100 µM). During the first 4 hours, spermatogonia reduced the DNA damage as measured in 
%tail-DNA by 51.8% (repair of 5936 breaks), while adult testicular cells repaired 33.7% 
(≈3862 breaks). The t1/2 for the induced damage, as calculated from a single experiment, was 
4 hours for spermatogonia and 8 hours for adult testicular cells. Spermatogonia seemed to be 
able to repair all damage in the course of 24 hours (repair rate of approximately 11500 breaks 
per 24 hours), while approximately 18%tail-DNA is still measured in adult testicular cells 
(repair rate of approximately 8000 breaks per 24 hours). A posthoc test showed significantly 
more repair in spermatogonia than adult testicular cells after 4 and 24 hours after this DBCP 
exposure (p=0.034 and p<0.001, Dunnett`s T3)). 
Taken together the results show a slight trend towards faster repair in spermatogonia. 
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Figure 26: Repair of DNA damage after exposure to DBCP in adult testicular cells and in spermatogonia. 
The mean of medians from each gel is shown. Cells were not treated with Fpg. 
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3.4 Gene expression 
The gene expression of Bcrp1, Oat2, and P-gp was measured after one hour of exposure to 6:2 
FTOH, 8:2 FTOH or PFOA. RNA was isolated from the samples, cDNA was synthesized and 
real-time PCR was performed.  
The amount of RNA varied considerably between samples and was dependent on the 
amount of cells in the individual sample (figure 27). The average amount was 47.16±31.3 
ng/µl. Nevertheless, the amount of cDNA synthesized from the samples was more similar 
with an average amount of cDNA in the samples of 2297±279ng/µl. The purity of the RNA 
samples was 1.6 for the 260/230 ratio and 2.1 for the 260/280 ratio. A 260/280 ratio of ~2.0 is 
considered pure RNA, while the 260/230 ratio should be between, 2.0 and 2.2. The 260/280 
ratio of the samples was close to the desired value, while the 260/230 ratio was lower, which 
can indicate the presence of contaminants absorbing at 230. 
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Figure 27: Amount of RNA extracted as a function of number of cells in the sample. 
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Figure 28: Regression analysis of log cDNA dilution versus CT-value. Shown are the CT-values for the 5 
replicates of each gene (dots) as well as the regression line with the coefficient of determination (R2). The 
trend line for 18 S is y =-0,8307Ln(x) + 13,224, while the formula for the Bcrp1 trend line is y = -
1,2318Ln(x) + 28,842. The high R2 suggests high agreement between single measurements. Similar slopes 
of the two trend lines imply equal amplification efficiency. 
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Three genes were analysed using the real-time PCR. However, primers for two of the genes 
(Oat2 and P-gp) did not give a satisfactory result in the real-time PCR, although several 
primers were tested. A high CT-value and high levels of unspecific products resulted in the 
decision not to use the data obtained with Oat2 and P-gp primers. Only the expression of 
Bcrp1 is therefore analysed further.  
The linear regression analysis of log cDNA dilution versus CT-value is shown in 
figure 28. The high R2-value reveals that the linear regression is a good model for the dilution 
series, explaining 95 and 97% of the variation for Bcrp1 and 18S, respectively. It also shows 
that the technical replicates are very alike each other. Additionally, the analysis is used to find 
the best dilution to be used in the real-time PCR. A high CT-value leads to a lot of unspecific 
background, as well as unspecific products during the real-time, so a 0.1 dilution should be 
used, since 0.01 dilution gives a CT-value over 35 for Bcrp1. As previously described, the 2-
∆∆CT
-method assumes equal amplification efficiencies of the housekeeping gene and the target 
gene. A similar slope of the dilution curves for 18S and Bcrp1 implies that this assumption is 
valid.  
Taken together the results from the regression analysis suggest the use of a 0.1 dilution 
of the cDNA, and it supports the use of the 2-∆∆CT-method. 
The expression of 18S was reasonably stable in the different sample (figure 29), 
indicating no effect of the test compounds on expression of the housekeeping gene. 
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Figure 29: Variation in CT-value for the housekeeping gene 18S in the different samples. The mean value 
from the three samples with standard derivation is shown. 
 
Gene expression data for Bcrp1 were analysed statistically by two different methods, since 
neither method seemed to be flawless. The results from the Student’s t-test can be found in 
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table 7, while results from the second analysis can be found in appendix 7.5.6 (raw data, as 
well as log transformed data). Exposure to PFOA did not lead to significant changes in gene 
expression (figure 30). However, a significant difference from the control of two samples 
exposed to 6:2 FTOH (10 and 100 µM 6:2 FTOH) was observed in one of the experiments, 
where the fold change was reduced to 0.31 and 0.28, respectively. The second run of this 
experiment showed no significant difference between controls and exposed. Exposure to 8:2 
FTOH lead to a reduction in fold change to 0.52 and 0.40, for exposure to 10 µM and 100 µM 
8:2 FTOH respectively. This was significant as tested by the Student’s t-test in one 
experiment. The same exposure was significant in the second statistical approach (p=0.027 for 
univariate ANOVA), but the post hoc test showed no significant reduction (p=0.307 and p= 
0.917 for Dunnett`s test). The second experiment did not show significant reduction of gene 
expression after exposure to 8:2 FTOH. 
Taken together, the results indicate no clear trend of the expression of Bcrp1 after one 
hour exposure to PFOA, 6:2 FTOH or 8:2 FTOH. However, there was considerable variability 
between the experiments, as can be seen in figure 31. Differences between experimental runs 
is a commonly observed feature of the real-time PCR due to the high sensitivity of the method 
combined with technical errors. 
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Figure 30: Change in expression of Bcrp1 as a function of exposure. The mean 2-∆∆CT-values from both 
experimental runs are shown (dots) and the average of these two experiments. Blue dots represent 6:2 
FTOH, red dots 8:2 FTOH and green dots PFOA. 
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Table 7: Results from the Student’s t-test (df=5) of ∆CT-values from exposed samples versus control 
samples. The Fold change is also shown. P-values <0.0167 are considered significant and marked by an 
asterisk. 
 
Exposure Dilution of 
cDNA 
Fold change 
(2-∆∆CT) 
p-value 
10 µM 1:10 0.31 0.116 
100 µM  1:10 0.28 0.355 
300 µM  1:10 1.01 0.718 
10 µM  1:100 0.64 0.00004 * 
100 µM  1:100 1.33 0.0003 * 
 
 
6:2 FTOH 
300 µM  1:100 1.08 0.911 
10 µM  1:10 0.52 0.769 
100 µM  1:10 0.40 0.911 
300 µM  1:10 1.25 0.931 
10 µM 1:100 1.17 0.0029 * 
100 µM 1:100 1.03 0.004 * 
 
 
8:2 FTOH 
300 µM  1:100 0.95 0.228 
10 µM  1:10 0.72 0.156 
100 µM  1:10 0.28 0.424 
300 µM  1:10 0.62 0.0902 
10 µM  1:100 0.69 0.307 
100 µM  1:100 1.34 0.071 
 
 
PFOA 
300 µM  1:100 0.58 0.208 
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Figure 31: Alteration in expression of Bcrp1, expressed as 2-∆∆CT-value, after exposure to 6:2 FTOH, 8:2 
FTOH or PFOA. Results from two separate experiments with five technical replicates in each are shown. 
The bars represent mean 2-∆∆CT-values with standard deviation. A fold change value of 1 implies no 
change in gene expression relative to the control. A lower value suggests reduction in gene expression, 
while a value above 1 implies induction of the gene. 
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4. Discussion 
4.1 Experimental design 
Extrapolation from in vitro experiments to human toxicity 
In vitro systems cannot replicate the complex interactions of animals in vivo, but they can 
provide important predictive information about the biological activity of a compound. Yet, 
one has to keep in mind that primary cell cultures prepared from one animal have limited 
probative force/conclusiveness since they only represent the reaction of one individual from 
one species. In the experiments presented here, cells were always pooled from at least two 
animals, somewhat increasing the predictive power of the results. Yet, due to this design, 
some information about individual variation is lost. Primary cell cultures maintain many of 
their in vivo characteristics and can therefore be more appropriate for extrapolating to humans 
than cell lines. But care still has to be taken to interpret these data, especially when 
extrapolating from one species to another (here, rats to humans). The extrapolation from 
laboratory experiments to humans includes also an extrapolation from very high 
doses/concentrations used in experiments to low levels of the test compound found in 
humans. In this study, cells are exposed to PFOA at concentrations up to 300 µM, while 
typical levels in human blood samples are 0.01 µM. Additionally, it is important to not only 
know the mechanism of toxicity of a compound, but also the shape of the dose-response curve 
in order to be able to extrapolate correctly.  
As described earlier, both PFCs and DBCP show very dissimilar responses in different 
species. The main differences in response to PFCs are the vast differences in elimination half-
lifes and differences with respect to PPARα-induction. The much longer half-life in humans 
makes PFCs potentially more hazardous to humans, while the lack of response to PPARα-
inducers in humans suggest a lower susceptibility. Vast differences regarding the response in 
different species have also been reported for the effects of DBCP; some species, like the 
hamster, show almost no susceptibility towards DBCPs effect on testicular cells, while others 
are highly susceptible. The induced testicular damage has previously been shown to be related 
to DNA damage induced in vitro in the different species. In vitro exposure of human testicular 
cells showed hardly any measurable induction of DNA damage (Bjørge et al., 1995). These 
large species differences make extrapolation less precise, and sometimes the extrapolation 
may even be misleading. 
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False positive and false negative results 
A false positive effect can be observed when the vehicle used gives a positive response in the 
assay. All tested compounds were dissolved in DMSO. The effects of DMSO on cytotoxicity 
and the induction of DNA damage were therefore tested. No cytotoxic effect was found at the 
used concentrations, and no measurable DNA damage was induced. 
Additionally, false positive results in the comet assay can be due to DNA degradation 
resulting from cell death, and thereby a secondary effect of cytotoxic effects of a compound, 
in contrast to a genotoxic effect. Viability of cells was therefore monitored prior to the comet 
assay, and was always found to be >90%. It is therefore unlikely that cytotoxicity caused false 
positive results in the comet assay.  
False negative results can possibly be obtained due to short exposure times. Both 
cytotoxicity and induction of DNA damage can occur only after prolonged exposures, but 
especially the investigation of changes in gene expression is dependent on either long 
exposure times or some post exposure time. Primary cell cultures of testicular cells in 
suspension are prone to both false negative and false positive results due to the suboptimal 
culture conditions, especially during prolonged culturing. One way of avoiding this could be 
in situ incubation of the cells in seminiferous tubules. Here, the supporting tissue and 
especially Sertoli cells are present, which has been shown to reduce apoptosis and increase the 
repair rate of DNA damage (Bentley and Working, 1988b; Bentley and Working, 1988a). 
A false negative result can be obtained if the tested compound is not stable under 
experimental conditions. Both fluorotelomer alcohols (FTOHs) are volatile compounds and 
some loss of the compounds by evaporation during exposure cannot be excluded. 
Unfortunately, no measurement of exposure concentration could be done at the end of 
exposure. 
Another possible reason for a false negative result in the comet assay is a selection of 
undamaged cells. It is conceivable that some cells are heavily damaged, which can lead to 
apoptosis or necrosis. These cells can be lost during washing steps and are therefore possibly 
not seen in the comet assay. This could have been controlled for by measuring the number of 
cells observed in the comet assay at the various exposure concentrations. Alternatively one 
could monitor the amount of DNA in the supernatant after centrifugation. An increase in 
DNA amount in the supernatant would be due to an increase in dead cells and thus selection 
of undamaged cells. 
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Statistical analysis of comet data 
All experiments using the comet assay were performed twice. To be able to perform a proper 
statistical analysis, results from three independent experimental runs are necessary. Due to 
time constraints, it was not possible to perform a third experiment. Nonetheless, the data 
obtained in the two experimental runs are analyzed statistically to look for trends. 
Data obtained by the comet method are usually not normally distributed. Also in this 
study, all comet data failed the normality test, as well as the test for homogeneity of variance. 
These findings suggest the use of non-parametric tests. The usefulness of non-parametric tests 
(Kruskal-Wallis and Mann-Whitney test) was investigated by Duez et al. (2003). These 
authors considered the single cell to be the experimental unit and found non-parametric 
methods to be overly sensitive, detecting significant, but objectively unimportant, differences. 
However, this might be due to the erroneous use of the single comet as the experimental unit, 
resulting in a very large n (n=100). 
The experimental design is nested and non-parametric tests can not be used in nested 
analysis. A possibility would have been to analyse the data with a parametric analysis of 
median values obtained in each gel. This would bring about a loss of information, as 
experiment and gel number can not be factors in this analysis. Also, the power of this analysis 
would be quite low, since n=6. In addition, the distribution of the data is different in control 
and treatment groups: data obtained from gels in which cells have little DNA damage are right 
skewed, while data from gels with highly damaged cells are left skewed. Non-parametric tests 
do not require normality, but they require similar distribution in all groups. There is however 
some discussion regarding how strict this requirement is (Zar, 1996).  
Another possibility is transformation of data using various functions, which sometimes 
can increase normality and homogeneity of variances. In this study log transformation was 
tested and no improvement of the data quality with respect to normality or homogeneity was 
found.  
ANOVA is thought to be a fairly robust method, so even if some of the underlying 
assumptions (independence of observations, normality, and homoscedasticity) are not 
fulfilled, it might still be used. It is assumed that it can be conducted when the variances differ 
by a factor of two and where normality is a minor violation (van Belle, 2002). The variances 
between samples were found to differ by a factor of up to 5 in this study, and data were often 
far from normal as detected by the Kolmogorov-Smirnov test. This test is a goodness-of-fit 
statistics which can be overly sensitive when the sample size is large because real data are 
unlikely to be perfectly distributed (Conover, 1980). In addition, there are 150 data points per 
exposure and experiment, making the central limit theorem applicable: the means of a random 
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sample will be normally distributed as the sample size increases, although the original data is 
not normally distributed, since the sum of independent samples from any distribution with 
finite mean and variance converges to the normal distribution as the sample size goes to 
infinity (Zar, 1996). 
For reasons mentioned here, statistical analysis of comet data is challenging. As Lovell 
put it: “There is unlikely to be a single correct statistical analysis for all designs, but there are 
a number of potentially wrong analyses” (Lovell and Omori, 2008). The nested ANOVA was 
chosen in this study as the best method available. However, one must not forget that the 
underlying assumptions, homogeneity of variance and normality, are violated and 
experiments were only performed twice, so care has to be taken when analysing the results of 
the ANOVA. The heteroscedaticity (heterogeneity in variance) of the data results in a lower 
power of the tests and thus a lower probability of rejecting a false null hypothesis. 
 
 
4.2 Polyfluorinated compounds 
The toxicity of 6:2 FTOH, 8:2 FTOH, and PFOA was tested in adult testicular cells from rats. 
These cells consist primarily of spermatids; the remaining cells are spermatocytes, 
spermatogonia and Sertoli cells.  
4.2.1 Cytotoxicity 
Cytotoxicity was evaluated by the Trypan Blue exclusion test. Viability was not reduced after 
one hour of exposure to 6:2 FTOH, 8:2 FTOH or PFOA at concentrations up to 300 µM. This 
is in compliance with results by Martin et al. (2005) who found no increased cell mortality 
after exposure to either 8:2 FTOH or 6:2 FTOH at concentrations up to 200 µM for 4 hours 
(Martin et al., 2005). The same conclusion was reported by Liu et al. (2007): Exposure to 6:2 
or 8:2 FTOH at concentrations up to 1.1x10-5M (11 µM) for 44 hours did not reduce cell 
viability in primary cultured Tilapia hepatocytes (Liu et al., 2007a). However, 200 µM PFOA 
for 24 hours led to apoptosis in the human hepatoblastoma HepG2 cells (Mulkiewicz et al., 
2007). Although we observed no cytotoxicity after one hour of exposure, a cytotoxic effect of 
the compounds after prolonged exposure cannot be excluded. 
In addition, the sensitivity of the Trypan Blue Exclusion test is debatable. Storer et al. 
(1996) suggest that the Trypan Blue exclusion test is not an appropriate method for detecting 
cytotoxicity, since loss of membrane integrity can be a late event in toxic cell death. The 
authors suggested the use of a delayed Trypan Blue exclusion test 3 hours after the exposure. 
Others suggest that the Trypan Blue exclusion test is overly sensitive since it measures 
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membrane instability, which can be due to other causes than chemical induced cytotoxicity, 
for instance excessive pipetting or centrifugation (Collins et al., 2008). Another method that 
could have been used here is the staining with propidium iodide (PI) and Hoechst in order to 
distinguish between apoptosis and necrosis of exposed cells. This method is more sensitive 
than the Trypan Blue exclusion test. Additionally, the MTT assay could have been used 
4.2.2 DNA damage 
The induction of DNA damage in adult testicular cells was evaluated using the comet assay. 
Neither 6:2 FTOH, 8:2 FTOH nor PFOA led to a significant increase in DNA damage as 
measured by the Comet assay after one hour of exposure to concentrations up to 300 µM. 
However, the observed power of the applied statistical test was low, as previously discussed. 
This can lead to not rejecting a false null hypothesis. In this case the result from the statistical 
analysis can therefore lead to the conclusion that the PFCs tested did not induce DNA damage 
although they actually do. Nonetheless, unexposed cells are expected to have 5-15%tail-DNA. 
None of the treatments led to a median value above 15%tail-DNA. The comet assay is a very 
sensitive assay for detecting strand breaks and alkalilabile sites. When including the repair 
enzyme Fpg, ring-opened purines and 8-oxoguanine, and possibly some small adducts, are 
detected in addition to single strand breaks. Since %tail-DNA did not increase in cells 
exposed to 6:2 FTOH, 8:2 FTOH, or PFOA, it can be assumed that the test compounds did 
not induce significant numbers of single strand breaks, AP sites, ring-opened purines or 8-
oxoguanine during this short in vitro exposure.  
These results are in compliance with findings by Stankowski (2001) who showed that 
8:2 FTOH was not mutagenic in the Salmonelle/Escherichia coli mutation assay, as well as 
findings by Freire et al. (2008) who reported no mutagenic effect of PFOA. Takagi et al. 
(1991) found an increase of 8-hydroxydeoxyguanosine (8-OH-dG) in the liver of rats after 
exposure to PFOA. However, the authors argue that this was a secondary effect of the 
peroxisomal proliferation caused in the liver and not a direct oxidizing effect of PFOA. 
Panaretakis et al. (2001) suggest that PFOA can induce oxidative stress by disrupting the 
inner membrane of the mitochondria. This suggests that PFOA exposure could lead to 
increased oxidative DNA damage. However, this was not observed in this study. 
It has to be kept in mind, though, that cells were only exposed for one hour. The expert 
panel for developing guidelines for the use of the comet assay in genetic toxicology suggest 
an exposure period of 3 to 6 hours (Tice et al., 2000), and it is possible that an effect on the 
DNA could have been observed after longer exposure times.  
In some of the experiments, a possible negative trend of %tail-DNA with increasing 
exposure was seen (see appendix 7.5.2, PFOA). This was not significant, but can possibly 
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suggest a DNA cross-linking effect of the compounds or an inhibition of repair enzymes, 
leading to a lower incision rate. Cross-linking is expected to be caused by agents with two 
reactive groups, for instance two epoxides. Neither the FTOHs, nor PFOA is expected to have 
this property. Because of this, coupled with time constraints, the possible cross-linking effect 
was not further addressed in this study. Another explanation of reduced %tail-DNA with 
increased exposure is an inhibition of repair enzymes such as DNA-glycosylases. These 
enzymes induce incision-related breaks as the initial step of DNA repair, which will appear as 
single strand breaks in the comet assay. An inhibition of these enzymes would lead to higher 
levels of DNA damage as 8-oxoG, but less incision-related breaks. Vanden Heuvel et al. 
(1992) suggested that PFOA binds to sulfhydryl groups of proteins. This is a common 
mechanism of enzyme inhibition, supporting the theory that PFOA might inhibit DNA repair 
enzymes. However, at the tested concentrations the effects were very small, so this is most 
likely not an important toxicity mechanism for PFOA. To test whether PFOA actually does 
inhibit repair enzymes a known amount of DNA damage could be induced by exposure to 
another chemical, UV- or X-ray, followed by incubation with PFOA. If PFOA actually 
inhibits repair enzymes, a reduced repair rate should be observed in cells with high PFOA 
exposure. 
It must also be remembered that the comet assay can be used to show genotoxicity of a 
compound, but cannot demonstrate the lack of genotoxicity, since not all types of DNA 
lesions can be detected in a standard comet assay. For instance, bulky adducts are not 
measured in the standard comet assay. It is however possible to observe these and other 
lesions by inhibiting DNA polymerase or ligase, which leads to the accumulation of single 
strand breaks (SSBs) formed as an intermediate step in the repair of DNA lesions. The SSBs 
can then be measured in the comet assay. Cytosine-1-β-D-arabinoduranoside (AraC) or 
aphidicolin could have been used in these co-exposure experiments (Friedberg et al., 2006). 
However, this method can only be used in cell types with active NER. The cells in the current 
study have probably little or no efficient NER, making it impossible to detect bulky adducts 
with the comet assay. 
It is in addition unclear whether the compounds were metabolized. A metabolic 
product of the compounds may be biologically more active. In order to reduce this possible 
false negative result, cellular genotoxicity tests often require the addition of hepatic S9 from 
Aroclor 1254-induced rats or another source of metabolic activation.  
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4.2.3 Gene expression 
An inhibition of effluent transporters such as P-gp, Bcrp1 and Oat2 could lead to intracellular 
accumulation and a higher toxicity of harmful substances, also known as chemosensitization. 
This is a quite severe feature of a compound since it blocks one of the basic lines of biological 
defence and reverses natural resistance. Smital and Kurelec (1998) showed an increase in 
single strand breaks and DNA adducts after exposure to compounds that inhibit efflux pumps. 
Non-functional effluent pumps at the blood-testis barrier might be especially serious, leading 
to an increased exposure of maturing germ cells in their most sensitive stages. 
Because of the seriousness of intervention with these protective measures and because 
of previous studies showing an inhibition of P-gp following exposure to PFOA (Stevenson et 
al.2006), the expression of the breast cancer resistance protein (Bcrp1), organic anion 
transporter 2 (Oat2), and P-glycoprotein (P-gp) in adult testicular cells was assessed using 
real-time PCR. The suspension with adult testicular cells consists of mainly spermatids. This 
expression of Bcrp1 has previously been shown on apical side of myoid cells and on the 
luminal side of the capillary endothelial cells (Bart et al., 2004). 
The real-time PCR results for Oat2 and P-gp were not satisfactory due to high amounts 
of unspecific products formed in some samples, and no product formation in other samples. 
This can be due to unspecific primers, contamination of RNA, as suggested by the low 
260/230 ratio, or low expression in the examined cells. Constituent expression of Oat2 and P-
gp in rat testicular cells had been reported previously (Augustine et al., 2005). However, 
Melaine et al. (2002) found no constituent expression of P-gp in mitotic and meiotic germ 
cells, but only in spermatozoa. Bart et al. (2004) report expression of P-gp in endothelial and 
myoid cells of the testis. The main cell type in the cell suspension obtained from adult rats is 
spermatids. It is therefore debatable whether low constituent expression of P-gp in the cell 
sample can explain the unsatisfactory result from the real-time PCR. 
The function of the P-gp transporters has been shown to be inhibited after exposure to 
several PFC, among others PFOA, in mussel cells by Stevenson et al. (2006). The inhibition 
led then to an induction of the P-gp protein as measured by Western blot analysis 48 hours 
after the exposure. Due to the poor result of the real-time PCR for P-gp, it is unknown 
whether PFOA or FTOHs influence this pump in testicular cells.  
As described earlier, the results from the real-time PCR with Bcrp1 were analyzed by 
several statistical methods. The stability of the housekeeping gene in all tested samples 
indicates that the chosen gene (18S) actually is unaffected by the tested compounds, and that 
it was appropriate as an internal standard. Furthermore, the regression analysis of different 
cDNA dilutions indicated that the 2-∆∆CT-method could be applied. Due to the small sample 
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size and discussion concerning the best statistical analysis of real-time PCR data, two 
different methods were tested; Student’s t-test and univariate ANOVA. Since both analyses 
came to the same conclusion in most cases, the results seem reliable.  
PFOA did not significantly alter the expression of Bcrp1 after one hour of exposure at 
concentrations up to 300 µM. The picture is however more complicated for both 6:2 FTOH 
and 8:2 FTOH. Both statistical analyses showed that two samples from the first experiment 
exposed to 6:2 FTOH were significantly different from the control: samples exposed to 10 
µM and 30 µM 6:2 FTOH had lower expression of Bcrp1. The cells exposed to 300 µM 6:2 
FTOH did not show this effect. The second experiment showed no significant differences 
between control and treatment in either analysis. However, analysis of the second experiment 
revealed a lack of homoscedasticity, which can lead to type II error (not rejecting a false null 
hypothesis). Based on data from this study, it is therefore not possible to conclude whether or 
not 6:2 FTOH leads to downregulation of Bcrp1 in rat testicular cells. With respect to 8:2 
FTOH, two of the exposed samples showed significant reduction of Bcrp1 expression when 
analyzed by the Student’s t-test (10 µM and 100 µM 8:2 FTOH). However, the analysis by 
univariate ANOVA followed by a Dunnett`s test did not corroborate the statistical 
significance of this reduction. The second experiment showed no difference by any sample 
compared to the control. In conclusion, it is possible that 6:2 FTOH and 8:2 FTOH reduced 
Bcrp1 expression, but the data from the experiments were inconclusive. However, the 
inhibitory effect on gene expression was only seen at 10 µM and 100 µM, but not at 300 µM. 
This lack of an increase of the effect with increasing exposure concentrations might indicate 
that the differences found were not due to a biologically response but rather due to variability 
of the method combined with relatively large technical errors. 
Other authors have reported an effect on gene expression after longer exposure periods 
than one hour; for example Ebert et al. (2005) showed an induction of BCRP1 in Caco-2 cells 
by different flavanoids after 48 hours of treatment only. Therefore it cannot be concluded that 
the tested polyfluorinated compounds have no effect on the expression of Bcrp1 in rat 
testicular cells, since the effect might be manifested after prolonged exposure times or post 
exposure times.  
 
Taken together, the presented results suggest that 6:2 FTOH, 8:2 FTOH and PFOA have no 
damaging effect on adult testicular cells from rats after one hour of exposure to concentrations 
up to 300 µM. Nonetheless, an effect on effluent transporters cannot be excluded, especially 
due to the short exposure time. The typical level of PFOA in human blood samples is 5 ppb 
which is equivalent to 0.01 µM, so the concentrations of PFOA tested here are much higher 
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than the normal exposure. Assuming that an exposure to 300 µM represents a no observed 
adverse effect level (NOAEL), the margin of exposure (MOE) is calculated to be 30,000. This 
is in compliance with the risk assessment done by Butenhoff et al. (2004a). One would 
normally consider a factor of > 100 to be safe with respect to non-carcinogenic effects, while 
a factor > 10,000 is considered safe for carcinogenic effects. To sum up, the MOE seems to be 
sufficient to assume that PFOA does not lead to testicular toxicity in the general population. 
So far the FTOHs have not been measured in human blood due to technical difficulties. It is 
therefore not possible to estimate human exposure based on direct measurements, making it 
impossible to calculate a MOE for these substances. 
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4.3 1,2-dibromo-3-chloropropane (DBCP) 
Earlier studies have shown that DBCP can act as a mutagen and clastogen (Rosenkranz, 1975) 
and induces DNA damage in testicular cells (Brunborg et al., 1988). The effect of DBCP 
regarding cytotoxicity and induction of DNA damage in adult testicular cells, spermatogonia, 
and somatic cells was evaluated. In addition, in the present study the repair capacity of 
spermatogonia and adult testicular cells was evaluated. 
Exposures with up to 100 µM DBCP for one hour did not decrease viability of 
spermatogonia. One of the three experiments where adult testicular cells were exposed to 
DBCP showed a reduction in viability at 10 µM DBCP. However, this result was of 
borderline significance (p=0.049). In the groups treated with 30 µM DBCP, no reduction in 
viability was found. These results suggest no cytotoxicity of DBCP on testicular cells from 
adult rats and spermatogonia at the concentrations tested after one hour of exposure. 
Omnichinski et al. (1988b) found no cytotoxic effect of DBCP on testicular cells after in vitro 
exposure to 1 mM, while severe cytotoxicity was observed at 2.5 mM. These findings are in 
compliance with the results in our study. 
DBCP was found to induce DNA damage in all testicular cell types. This is consistent 
with findings of others, including Brunborg et al. (1988) and Labaj et al. (2005) ,as well as 
studies showing that DBCP can act as a mutagen and clastogen (Rosenkranz, 1975).  
The increase in %tail-DNA without the Fpg-enzyme represents single strand breaks or 
alkalilabile sites. Direct induction of strand breaks is not expected to occur following DBCP 
exposure, while AP sites can be due to unstable DNA adduct formation. This seems to be a 
reasonable explanation since several of the metabolites of DBCP can form adducts with DNA. 
as shown by Humphreys et al. (1991), who suggested the formation of DBCP adducts at the 
N7-position of guanine. As mentioned earlier, adducts can be stable or unstable, but mainly 
unstable DNA adducts are measured in the comet assay (as AP sites). However, adducts that 
are stable under physiological conditions, can be unstable and lead to AP sites at the high pH 
used in the comet method. The formation of adducts at the N7-position is expected to lead to 
unstable adducts under physiological conditions (Cavalieri et al., 2000). The addition of Fpg 
in the comet assay led to an increase of %tail-DNA compared to cells not treated with Fpg. 
This suggests that DBCP also induces 8-oxoG, ring-opened purines or small adducts. 
However, the amount of Fpg-sensitive sites was far less than damage observed without Fpg 
treatment. It seems therefore that DBCP induces mainly abasic sites as a secondary product of 
adduct formation, plus some Fpg-sensitive sites.  
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One part of this study was to evaluate the susceptibilities of different testicular cell types. 
With respect to DNA damage such differences in different cells can have several 
explanations:  
• Differences in uptake efficiency of the test compound,  
• differences in metabolism and thereby bioactivation of the parent compound or  
• differences in repair capacity of the induced damage.  
During in vivo treatment the exposure of cells will differ depending on where they are situated 
in relation to the blood-testis-barrier (BTB), with spermatogonia and Sertoli cells receiving 
higher exposures than spermatocytes, spermatids and sperm cells. There are, however, no data 
available suggesting a difference in uptake in the three cell types in vitro. As described earlier, 
DBCP is bioactivated to reactive episulfonium ions by GST in the testis. The amount of GST 
has been shown to increase during spermatogenic cell development (Grosshans and Calvin, 
1985); this will most likely lead to a higher bioactivation rate in later stages of 
spermatogenesis and thereby higher levels of DNA damage. The repair capacity is most likely 
reduced in spermatids compared to spermatogonia, as discussed in more detail below. These 
differences in repair rate can contribute to differences in observed damage levels. During the 
exposure period an equilibrium will eventually become established between formation of new 
damage induced by DBCP, and repair of these lesions. DNA damage caused by DBCP in 
testicular cells has been shown to be induced quite rapidly with a measurable increase as early 
as 10 minutes after the start of in vitro exposure (Brunborg et al., 1988). However, in the 
same study it was shown that the amount of DNA damage increased throughout 60 minutes of 
exposure, suggesting that the equilibrium between newly induced lesions and repair was not 
reached during this period. It can therefore be assumed that differences in DNA damage 
induced in the different cell types in this study are, to a small part but not mainly, caused by 
different repair capacities.  
To sum up, the differences in the level of DNA damage is most likely due to 
differences in bioactivation of DBCP, with distinctions in repair rate contributing to a lesser 
part in this study. 
As described earlier, three different cell types were isolated: 1) testicular cells from 
adult rats, containing mainly spermatids but also spermatocytes and somatic cells, 2) cells 
obtained from prepubertal rats and incubated for one hour in lectin coated dishes, consisting 
of mainly spermatogonia (82%), and 3) cells from prepubertal rats incubated for 24 hours, 
consisting of near equal amounts of spermatogonia and somatic cells. We observed a 
difference in susceptibility towards DNA damage in the different cell types: The highest level 
of DNA damage was observed in the suspension consisting of spermatogonia and Sertoli 
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cells, which suggests that Sertoli cells are highly susceptible to DNA damage caused by 
DBCP. This is in accordance with the high levels of GST and GSH in Sertoli cells reported by 
Bauche et al. (1994). However, Bjørge et al. (1995) reported a higher susceptibility towards 
DNA damage caused by DBCP in round spermatids than in Sertoli cells. Our findings suggest 
a higher susceptibility of Sertoli cells. Yet, there are some confounding factors in these 
experiments: The somatic cells were cultured 24 hours on lectin dishes prior to exposure. The 
prolonged incubation of these primary cells can lead to higher levels of DNA damage due to 
suboptimal cultivation conditions, which itself can bring about damage to the DNA. A 
somewhat higher level of DNA damage observed in the control cells supports this hypothesis. 
Another reason for higher levels of DNA damage can be higher levels of GSH or GST in cells 
incubated for 24 hours after isolation. This would lead to higher bioactivation ratios of DBCP 
to the reactive episulfonium ion and thereby higher DNA damage levels. Freshly isolated cells 
can potentially have a depleted GSH or GST depot, resulting in lower bioactivation of DBCP. 
This theory is supported by observations made previously in our laboratory (Brunborg, 
personal communication). Whether the prolonged incubation time causes the increased level 
of DNA damage could be tested by also incubating the other two cell samples for 24 hours 
prior to exposure.  
DBCP induced different levels of DNA damage in spermatogonia and spermatids, but 
the difference in response was not very distinct. However, the available data showed a trend 
towards less DNA damage induced in spermatogonia, as well as faster repair in these cells 
after exposure to DBCP. Due to the higher levels of GST in spermatids compared to 
spermatogonia reported by Grosshans and Calvin (1985), a higher bioactivation rate in 
spermatids and therefore also higher levels of DNA damage were expected in spermatids, 
which is in compliance with our findings. Meistrich et al. (2003) found seminiferous tubule of 
DBCP exposed rats containing no differentiating germ cells, but proliferating and dividing 
type A spermatogonia. These spermatogonia did not undergo differentiation, but underwent 
apoptosis, thus suggesting that the oligospermia is not due to a loss of stem cells, but due to a 
block in differentiation (Meistrich et al., 2003). This block could be due to DNA damage in 
the stem cells, leading to an arrest of DNA replication and thereby cell proliferation.  
Our results suggest therefore the following sensitivity towards DNA damage induced 
by DBCP: Sertoli and other somatic cells > spermatids > spermatogonia. 
Biava et al. (1978) found seminiferous tubules from exposed individuals to be lacking 
germ cells, and concluded that spermatogonia and later stages of germ cells were more prone 
to the effect of DBCP. Such findings in humans are not reflected in our study. Amann and 
Berndtson (1986) found a reduction in spermatocytes/Sertoli cell-ratio, which also was 
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interpreted as evidence towards the higher susceptibility of germ cells. However, if Sertoli 
cells are severely damaged they might not be able to support the differentiating germ cells, 
which could lead to apoptosis of germ cells and thereby seminiferous tubuli lacking these cell 
types. This is supported by findings of Zhang et al. (2007) who showed that radiation, which 
leads to infertility due to azoospermia, causes damage in the supporting tissue, and not the 
germ cells/spermatogonia. It is possible that the same mechanisms are causing infertility after 
DBCP exposure, with Sertoli cells being more severely damaged then the spermatids and 
spermatogonia. 
 
Taken together the results suggest a clear DNA damaging effect of DBCP to all 
testicular cell populations studied. Possible consequences are cellular dysfunction, cell death, 
or mutations. Mutations in germ cells are especially serious since they can impair fertility, 
increase abortion rate or lead to genetic disorders in offspring. Mutation occurring in germ 
cells during childhood have a greater likelihood of being transferred to offspring since germ 
line stem cells (spermatogonia) in children will have more opportunity to produce mutant 
mature germ cells than mutant germ line stem cells formed in adults (Xu et al., 2008). Sertoli 
cells might be more susceptible towards to DBCP toxicity than spermatids and 
spermatogonia. The damaging effects on Sertoli cells can disturb or inhibit spermatogenesis 
and thereby reduce fertility or lead to infertility. This effect can be due to an impairment of 
the ability to provide nutritional and other supportive functions for the developing germ cells. 
In addition, Sertoli cells have an important role in the blood-testis barrier by maintaining tight 
junctions and transporting xenobiotics out of the adluminal compartment. In addition, the 
BTB protects germ cells from autoimmunity, a disturbance of the BTB can therefore induce 
autoimmunity. A disturbance of Sertoli cells can therefore lead to less protection of maturing 
germ cells, leading to increased chemical insults. Damage to Sertoli cells can therefore have 
an indirect effect on toxicity of xenobiotics towards germ cells. However, these results must 
be interpreted with caution as the effect of the longer preincubation time is not known. 
4.3.1 Repair capacity 
Whether the induced DNA damage in testicular cells has an effect on fertility and induction of 
cancer development depends both on the amount and types of damage induced, but also on 
the repair of the damage. Because of this, the efficiency to repair DNA damage induced by 
DBCP was evaluated in spermatogonia and spermatids.  
The experiments examining repair capacity were in this study carried out in an 
incubation chamber containing only 5% O2. Inside the testicle, testicular cells are exposed to 
approximately the same oxygen concentration, and previous experiments in our lab and other 
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labs have shown that primary testicular cells have reduced viability and increased DNA 
damage when incubated for extended time periods at 20% O2 (Brunborg, personal 
communication, (Erkkilä et al., 1999)).  
There was no reduction in total %tail-DNA in cells treated with Fpg during 24 hours 
of incubation, so the amount of net Fpg-sensitive sites was not significantly changed during 
24 hours incubation after DBCP exposure (appendix 7.5.5). This is likely due to the cells 
being exposed to reactive oxygen species during incubation and due to oxidative damage 
caused by handling of cells. This is in compliance with results by Torbergsen and Collins 
(2000) who found an increase in DNA damage in primary cultured lymphocytes during the 
first few hours after isolation. This suggests that the testicular cells were able to repair some 
of the oxidative damage, but about equal amount of new damage were induced 
simultaneously. 
In cells not treated with Fpg, a reduction of DNA damage was observed, indicating 
repair of single strand breaks and alkalilabile sites in both spermatogonia and round 
spermatids. The reduction in %tail-DNA can possibly be due apoptosis and following 
disintegration of heavily damaged cells, leading to a selection of cells with little DNA 
damage. However, cell viability as determined by the Trypan Blue Exclusion test showed 
viability >88% in all samples, so this seems an unlikely source of error. To ensure that 
apoptosis is not contributing to a sample error the number of cells in each sample should be 
monitored. Another possibility would be to add an enzyme that inhibits DNA repair to a 
parallel set of exposed cells. If a decrease in %tail-DNA would be observed in these samples 
as well, selection of cells rather than DNA repair would be the explanation. Bjørge et al. 
(1997b) report a repair of DNA damage induced by DBCP in spermatocytes, but not in 
spermatids, which is in contrast to our findings. 
The observed t1/2 in this in vitro study is likely to be longer than the actual repair rate 
in vivo because the cells in suspension lack the support from Sertoli cells (nutrition, growth 
factors etc). This hypothesis is supported by findings of Bentley and Working (1988b; , 
1988a) who observed 4-25 times higher repair rates in germ cells exposed in situ in 
seminiferious tubules than in germ cells exposed in suspension. 
A slight difference in the repair rate of spermatogonia and spermatids was observed. 
The results presented suggest a somewhat faster repair of DNA damage in spermatogonia than 
in spermatids. This is in compliance with findings by Matulis and Handel (2006) who found 
little repair in later stages of spermatogenesis. As described earlier, it has been suggested that 
BER is functional in all germ cell stages while NER is reduced in spermatocytes more or less 
absent in round spermatids (Jansen et al., 2001; Olsen et al., 2001; Xu et al., 2005; Matulis 
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and Handel, 2006). Small adducts, as are expected after DBCP exposure, are likely removed 
by both NER and BER. This is in compliance with our findings of active repair of DBCP 
induced lesions in both cells types with a higher repair rate in spermatogonia. 
Biologically, the reduced repair capacity in later stages of spermatogenesis might 
make sense, as these cells are somewhat protected by the blood-testis barrier from harmful 
components. Spermatogonia, however, are needed as a stock to provide germ cells during the 
reproductive phase of males, so effective and functional repair systems in these cells are 
highly meaningful.  
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5. Conclusions and future work 
The results obtained in this study suggest that 6:2 FTOH, 8:2 FTOH and PFOA have no 
severe detrimental effect on testicular cells from adult rats, and are not likely to have a 
negative impact on male fertility. However, none of the data have conclusive value due to few 
experiments with short exposure times and statistical tests with low observed power. 
Furthermore, the comet assay measures single strand breaks, abasic sites, oxidized guanine, 
and possibly some small adducts. We can therefore not deduce that the tested PFCs are not 
genotoxic, since other DNA lesions as bulky adducts are not measured in this assay. In 
addition, the actual exposure was not measured since the concentration throughout the 
exposure time was not monitored. Therefore longer exposure or post exposure times must be 
examined, both regarding cytotoxicity, induction of DNA damage and alteration in gene 
expression, together with control of concentrations during exposure. The longer incubation 
times might best be accomplished using in situ exposure of cells in seminiferous tubules. The 
expression of P-gp could be studied either by real-time PCR or with flow cytometric analysis 
of cells stained with anti-P-gp after prolonged exposure. Alternative methods are Western 
analyses or measurement of ATPase activity. Also, the potential enzyme inhibition by PFOA 
could be analysed with a modified comet assay as described earlier. To positively exclude 
genotoxicity, the compounds have to be tested in other genotoxicity assays as well. 
 Taken together with the data described in the literature study, the main effects of the 
polyfluorinated compounds in rodents seem to be an induction of peroxisomal proliferation, a 
detrimental effect on reproduction after in utero exposure, and a possible effect on hormone 
homeostasis and chemosensitization. The testicular toxicity, however, appears to be low. 
Whether human health is influenced by these substances remains inconclusive. The NOAEL 
values obtained in both in vitro and in vivo experiments suggest a high MOE for PFOA. No 
such value can be calculated for the FTOHs since no data exist on blood levels or exposure of 
these substances. Whether there actually is a risk posed to humans depends not only on the 
MOE-value, since the mode of action can be quite different in humans and rodents, which is 
particularly true for peroxisomal proliferation. 
 
DBCP is a known testicular toxicant in both humans and rats, but the mechanism of toxicity 
still remains somewhat unclear. The main mode of action appears to be induction of DNA 
damage leading to an arrest of differentiation of germ cells. The type of cells most affected is 
however still uncertain. In order to evaluate the induced DNA damage in different cell types, 
a method for isolation of different cell populations was needed. The isolation of testicular 
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cells from prepubertal rats, followed by one hour of incubation on lectin coated dishes, 
resulted in a cell population consisting of approximately 80% spermatogonia. The method is 
convenient and combined with the high purity of the appropriate cell types it seems to be a 
well fit method for isolation of spermatogonia. In this study, DBCP was shown to induce 
DNA damage in all cell types tested and a trend towards the following sensitivity was 
observed: Sertoli cells and other somatic cells > round spermatids > spermatogonia. The high 
susceptibility of Sertoli and other somatic cells observed can, however, be due to prolonged 
incubation prior to exposure. This needs to be examined further. The repair of the DNA 
damage seems to be higher in spermatogonia compared to round spermatids, but the results 
presented here are only preliminary, since they are based on only one experiment. More 
experiments are needed to strengthen the possible differences between cell types. Later on, it 
would be interesting to study the repair capacity in Sertoli cells as well.  
  
Taken together, the results suggest that DBCP can impair male fertility by damaging the DNA 
of several testicular cell types. In contrast, the selected polyfluorinated compounds showed no 
clear testicular toxicity. Nonetheless, this is no proof of a lack of toxicity, or as Albert 
Einstein put it: “No amount of experimentation can ever prove me right; a single experiment 
can prove me wrong”. 
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7. Appendix  
7.1 Chemicals 
Chemical Producer 
Dubeccos`s Phosphate Buffer solution (PBS) Locally produced 
Dimetyhylsulfoxide (DMSO) Merck, Germany  
Bovine serum, albumin (BSA) Sigma, USA 
Bio Whittaker® RPMI 1640 medium with 25mM Hepes and L-
Glutamin 
Lonza, Belgium 
Fetal calve serum (FCS) Gibco, NY, USA 
Sodium Pyruvate Sigma, Japan 
DL-Lactic acid Sigma, Norway 
P/S Sigma, Norway 
Collagenase type 2, 275 U/mg Worthington, USA 
Trypsin, 10200 U/mg Sigma, USA 
Lectin from Datur stramomium Sigma, USA 
Sodium chloride (NaCl) Merck, Germany 
Sodium Hydroxide (NaOH) Merck, Germany 
Hydrogen chloride (HCl) Merck, Germany 
Potassium hydroxide (KOH) Merck, Germany 
Potassium chloride (KCl) Merck, Germany 
Trizma® base (Tris (hydroxymethyl)-aminomethane, Tris-base) Sigma, USA 
Triton-X Sigma, USA 
Sodium lauryl sarcocinate Sigma, UK 
GelBond® Film Cambrex, USA 
Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) Sigma, USA 
Hepes Sigma, USA 
NuSieve GTG Low melting agarose Cambrex, USA 
Fpg crude enzyme extract Locally produced 
SYBR Gold Invitrogen, USA 
  
  
Perfluorooctanoic acid (PFOA) Wellington, Canada 
1H,1H,2H,2H-perfluoro-1-decanol (8:2 FTOH) Sigma-Aldrich, Japan 
1H,1H,2H,2H-Perfluoro-1-octanol (6:2 FTOH) Sigma-Aldrich, USA 
1,2-dibromo-3-chloropropane (DBCP) Dr. Nelson, USA 
  
SV Total RNA Isolation System, Cat #AZ3105 Promega, USA 
Reverse Transcription System, Cat # A3500 Promega, USA 
Bcrp primer (rBcrp1F and rBcrp1R) Sigma 
18S primer (H18S-F and H18S-R) Sigma 
Oat2 primer, Slc22a7 SuperArray 
Power SYBR Green PCR Master Mix Applied Biosystems, 
UK 
Distilled water, DNase and RNase free Gibco, USA 
  
Vimentin Clone V9, Mouse, Code No M0725 Dako AS, Denmark 
Secondary antibody, RRX anti-mouse Jackson Immuno 
Research, West Grove, 
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PA, USA 
Paraformaldehyd (PFA) Merck, Germany 
Hoechst 33258 Calbiochem-
Boehringer, USA 
Thimerosal Sigma, USA 
Trypan Blue Stain Cambrex, USA 
Polysine Microscope slides Menzel, Germany 
Absolute alcohol prima Arcus Kjemi, Norway 
Micro Amp 96-Well Reaction Plate Applied Biosystems, 
Singapore 
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7.2 Solutions and media 
Media 
Testis medium with serum: RPMI 1640 added 10% FCS, 0,1 mg pyruvat/ml, 5mM DL-Lactic 
acid, and 1% P/S 
 
Testis medium without serum: RPMI 1640 added 0,1 mg pyruvat/ml, 5mM DL-Lactic acid, 
and 1% P/S 
 
Solutions used in the comet assay 
Lysis stock solution: 
2,5 M NaCl, 100 mM EDTA, 10mM Trizma base, 12g/l NaOH. Adjust pH to 10. Add 1% 
Sodium lauryl sarcocinate. 
 
Lysis solution: 
Dilute stock solution 10 times, add 10% DMSO and 1% Triton-X 
 
Fpg-enzyme reaction buffer: 
40mM Hepes, 0,1 M KCl, 0,5mM EDTA. pH adjusted to 7,6. 
 
Unwinding and electrophoresis stock solution: 
10N NaOH, 200mM EDTA 
 
Unwinding and electrophoresis buffer: 
Dilute electrophoresis stock solution 10 times, adjust pH to 13,2 
 
Neutralization solution: 
0,4 M Trizma base, pH adjusted to 7,5. 
 
TE-buffer: 
1mM EDTA, 10mM Tris HCl, pH adjusted to 8,0. 
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7.3 Experimental design 
 
7.3.1 Cytotoxicity 
7.3.2 Comet assay 
7.3.3 Gene expression 
7.3.4 Repair capacity
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5 squares  
á 80 cells 
5 squares  
á 80 cells 
5 squares  
á 80 cells 
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á 80 cells 
5 squares  
á 80 cells 
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5 squares  
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5 squares  
á 80 cells 
5 squares  
á 80 cells 
5 squares  
á 80 cells 
Experiment 1 Experiment 2 Experiment 3 
Isolation of 
testicular 
Exposure to 
different 
concentrations 
Measuring cell 
viability 
7.3.1 Experimental design – Cytotoxicity 
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Experiment 1 Experiment 2 
50 nuclei 50 nuclei 50 nuclei 50 nuclei 50 nuclei 50 nuclei 50 nuclei 50 nuclei 
Exposure to 
different 
concentra-
tions 
Isolation of 
testicular cells 
Molding 
Scoring 
7.3.2 Experimental design – Comet assay 
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Experiment 1 Experiment 2 
Exposure 
to different 
concentra-
tions 
Isolation of 
testicular cells 
RNA isolation 
cDNA 
synthesis 
Real-time 
PCR 
7.3.3 Experimental design – Gene expression 
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apacity
 7.3.4 Experimental design – DNA repair capacity 
Exposure to 0, 3, 10, 30 or 100 µM 
0        1         2        4          8       24 hours 0        1         2        4         8       24 hours 
0         1          2              4                   8                24 hours 
0                  1          2             4                 8               24 hours 
Different repair times 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
50 
comets 
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7.4 Table of test chemicals 
 
Common name Abbreviation Chemical name Chemical structure CAS number 
Dibromochloropropane DBCP 1,2-dibromo-3-chloropropane CH2BrCHBrCH2Cl 96-12-8 
Perfluorooctanoic acid PFOA Perfluoro-n-octanoic acid C8HF15O2 335-67-1 
8:2 fluorotelomeralcohol 8:2 FTOH 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluoro-1-decanol 
CF3(CF2)7CH2CH2OH 678-39-7 
6:2 fluorotelomeralcohol 6:2 FTOH 3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluoro-1-octanol 
CF3(CF2)5CH2CH2OH 647-42-7 
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7.5 Additional results 
7.5.1 QQ-plots of data from the comet assay 
 
 
 
 
QQ-plots for %tailDNA from cells treated with 0 µM DBCP (top left), 3 µM DBCP (top right), 10 µM 
(bottom left) and 30 µM DBCP (bottom right). 
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7.5.2 Comet results from PFCs, with and without Fpg 
 
Comet data for testicular cells exposed to 6:2 FTOH, 8:2 FTOH or PFOA.  
Red dots represent median values from each gel treated with Fpg, while green dots represent 
median values from each gel without Fpg. The lines represent the mean value of the medians. 
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7.5.3 Testing of logtransformation of Comet data 
Data obtained in the comet assay were analyzed regarding their normality and 
homoscedasticity. In addition, p-values from the univariate ANOVA of the nested data 
together with F-values are shown. The data were also logtransformed, and the same analysis 
was carried out with the logtransformed data. 
 
Results of the statistical analysis testing whether logtransformation of Comet data alters results. Shown 
are p-values for normality (p<0.05 meaning that the data are not normally distributed), p-values for 
homogeneity of variance (p<0.05 meaning that the data do not have equal variance), F-value for 
univariate ANOVA and p-values from the univariate ANOVA. Asterisks indicate significance. 
 
Parameter Raw data Logtransformed data 
Normality <0.001 * <0.001 * 
Homogeneity of 
variance 
<0.001 * <0.001 * 
F-value from 
ANOVA 
90.652 85.247 
Spermatogonia 
exposed to DBCP, 
gels treated with Fpg 
p-value from 
ANOVA 
<0.001 * <0.001 * 
Normality <0.001 * <0.001 *  
Homogeneity of 
variance 
<0.001 * <0.001 * 
F-value from 
ANOVA 
86.849 68.950 
Adult testicular cells 
exposed to DBCP, 
gels treated with Fpg 
p-value from 
ANOVA 
<0.001 * <0.001 * 
Normality <0.001 * <0.001 * 
Homogeneity of 
variance 
0.025 * <0.001 * 
F-value from 
ANOVA 
1.221 1.493 
Adult testicular cells 
exposed to 8:2 
FTOH, gels treated 
with Fpg 
p-value from 
ANOVA 
0.549 0.382 
Normality <0.001 * <0.001 * 
Homogeneity of 
variance 
<0.001* <0.001 * 
F-value from 
ANOVA 
2.548 2.226 
Adult testicular cells 
exposed to PFOA, 
gels treated with Fpg 
p-value from 
ANOVA 
0.329 0.216 
Normality <0.001 * 0.003 * 
Homogeneity of 
variance 
0.001 * <0.001 * 
F-value from 
ANOVA 
3.480 2.777 
Adult testicular cells 
exposed to 8:2 
FTOH, gels treated 
with Fpg 
p-value from 
ANOVA 
0.077 0.120 
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7.5.4. Dose-response models for DBCP-treatment of adult testicular cells. 
 
 
 
 
Plot of the linear model and the cubic model and the coefficient of determination for the models, together 
with a model summary. 
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7.5.5 Results from the DNA repair capacity analysis, results from cells 
treated with Fpg 
 
DNA damage measured in spermatogonia after exposure to DBCP. Results from cells treated 
with Fpg are shown. No distinct reduction in DNA damage was observed. 
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7.5.6 Results of statistical analysis of real-time PCR data – approach 2 
 
Results of the statistical analysis of data from real-time PCR. Shown are p-values for normality (p<0.05 
meaning that the data are not normally distributed), p-values for homogeneity of variance (p<0.05 
meaning that the data do not have equal variance), F-value for univariate ANOVA and p-values from the 
univariate ANOVA. Asterisks indicate significance. 
 
 
Results for Dunnetts test of control groups versus exposed groups for the exposures that did show 
significant differences in the univariate ANOVA. P-values for both raw data and log-transformed data are 
shown. Asterisks indicate significant results. 
Testing p-value for raw data p-value for log-transformed 
data 
control vs. 10 µM 6:2 FTOH <0.001 * <0.001 * 
control vs. 100 µM 6:2 FTOH 0.001 * 0.001 * 
control vs. 300 µM 6:2 FTOH  0.423 0.416 
control vs. 10 µM 8:2 FTOH 0.307 0.331 
control vs. 100 µM 8:2 FTOH 0.917 0.904 
control vs. 300 µM 8:2 FTOH 0.193 0.178 
 
Exposure Parameter Raw data Log transformed 
data 
Normality 0.827 0.736 
Homogeneity of variance 0.100 0.135 
F-value from ANOVA 11.787 11.876 
6:2 FTOH,  
1st experiment 
p-value from ANOVA <0.001 * <0.001 * 
Normality 0.742 0.757 
Homogeneity of variance 0.374 0.406 
F-value from ANOVA 3.981 3.978 
8:2 FTOH  
1st experiment 
p-value from ANOVA 0.027 * 0.022 * 
Normality 0.349 0.403 
Homogeneity of variance 0.025 * 0.037 * 
F-value from ANOVA 2.307 2.093 
PFOA  
1st experiment 
p-value from ANOVA 0.116 0.141 
Normality 0.270 0.192 
Homogeneity of variance <0.001 * <0.001 * 
F-value from ANOVA 1.78 1.77 
6:2 FTOH  
2nd experiment 
p-value from ANOVA 0.190 0.192 
Normality 0.444 0.247 
Homogeneity of variance 0.502 0.421 
F-value from ANOVA 0.114 0.160 
8:2 FTOH  
2nd experiment 
p-value from ANOVA 0.950 0.921 
Normality 0.922 0.884 
Homogeneity of variance 0.649 0.535 
F-value from ANOVA 1.362 1.425 
PFOA  
2nd experiment 
p-value from ANOVA 0.290 0.275 
